<!DOCTYPE html> <html class=js style lang=en><!--
 Page saved with SingleFile 
 url: https://www.nature.com/articles/s41525-021-00220-w 
 saved date: Mon May 30 2022 21:18:18 GMT+0200 (Central European Summer Time)
--><meta charset=utf-8>
<title>TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19 | npj Genomic Medicine</title>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=applicable-device content=pc,mobile>
<meta name=viewport content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<style>@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){html{box-sizing:border-box;font-family:sans-serif;font-size:100%;height:100%;line-height:1.15;overflow-y:scroll}body{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.76;min-height:100%}article,aside,header,main,section{display:block}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}svg:not(:root){overflow:hidden}button,input{font-family:sans-serif;font-size:100%;line-height:1.15}button,input{overflow:visible}button{text-transform:none}[type=submit],button{-webkit-appearance:button}button{border-radius:0;cursor:pointer}button,h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{letter-spacing:-.0390625rem}.u-h3,h2{letter-spacing:-.0117156rem}h2{font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem;margin-bottom:8px}.u-h3,h2{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-weight:700}.u-h3{line-height:1.4rem}h3{font-size:1.25rem}h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-weight:700;letter-spacing:-.0117156rem;line-height:1.4rem}body,button,div,form,h1,h2,h3,input{margin:0;padding:0}p{padding:0}body{font-size:1.125rem}p{margin:0 0 28px}ol,ul{margin-bottom:28px;margin-top:0}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}@media only screen and (max-width:539px){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-header__menu--global .c-header__item svg{display:none}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-author-list{color:#6f6f6f;font-family:inherit;list-style:none;margin:0;padding:0}.c-author-list>li,.c-breadcrumbs>li,.js .c-author-list{display:inline}.c-author-list>li:not(:first-child):not(:last-child):before{content:", "}.c-author-list>li:not(:only-child):last-child:before{content:" & "}.c-author-list--compact{font-size:.875rem;line-height:1.4}.c-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}.c-skip-link:link{color:#fff}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}.c-breadcrumbs__chevron{fill:#888;margin:4px 4px 0}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:8px 0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__row--flush{padding:0}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin-right:24px}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;line-height:1.4;list-style:none;margin:0 -8px;padding:0}.c-header__menu--global{font-weight:400;justify-content:flex-end}@media only screen and (min-width:540px){.c-header__menu--global .c-header__item svg{display:block}}.c-header__menu--journal{font-size:.875rem}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}@media only screen and (max-width:1023px){.c-header__menu--tools{display:none}}.c-header__item{display:flex}@media only screen and (min-width:540px){.c-header__item:not(:first-child){margin-left:8px}}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}@media only screen and (max-width:767px){.c-header__item--nature-research{display:none}}.c-header__row--flush .c-header__item{padding-bottom:8px;padding-top:8px}.c-header__link{align-items:center;color:inherit;display:flex;padding:8px;white-space:nowrap}.c-header__link>svg{margin-left:2px;transition-duration:.2s}@media only screen and (min-width:540px){.c-header__link>svg{margin-left:4px}}.c-header__show-text{display:none}@media only screen and (min-width:540px){.c-header__show-text{display:inline}.c-header__item--dropdown-menu{position:relative}}.u-button svg{fill:currentcolor}.u-button{align-items:center;border-radius:2px;cursor:pointer;font-family:sans-serif;font-size:1rem;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:768px){.u-show-at-md{display:block;visibility:visible}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-ma-0{margin:0}.u-mt-32{margin-top:32px}.u-mr-2{margin-right:2px}.u-mb-16{margin-bottom:16px}.u-mb-32{margin-bottom:32px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.u-lazy-ad-wrapper{background-color:#ccc;display:none;min-height:137px}@media only screen and (min-width:768px){.u-lazy-ad-wrapper{display:block}}}</style>
<style media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;height:100%;overflow-y:scroll;font-size:100%;box-sizing:border-box}body{min-height:100%;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;line-height:1.76;color:#222}article,aside,figcaption,figure,footer,header,main,section{display:block}figure{margin:0}a,sup{vertical-align:baseline}a{background-color:transparent;-webkit-text-decoration-skip:objects;color:#069;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word;text-decoration:underline;text-decoration-thickness:.0625rem;text-underline-offset:.08em}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative}sup{top:-.5em}img{border:0;max-width:100%;height:auto;vertical-align:middle}svg:not(:root){overflow:hidden}button,input{font-family:sans-serif;font-size:100%;line-height:1.15}button,input{overflow:visible}button{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}[type=checkbox]{box-sizing:border-box;padding:0}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}.c-article-box__controls button:focus,.c-article-box__controls button:hover,.c-pan-zoom-controls button:focus,.c-pan-zoom-controls button:hover,a:focus,a:hover{text-decoration:underline}button{cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;border-radius:0}abbr[title]{text-decoration:none}b:focus,dd:focus,div:focus,dl:focus,dt:focus,em:focus,h1:focus,h2:focus,h3:focus,h4:focus,h5:focus,i:focus,li:focus,ol:focus,p:focus,span:focus,strong:focus,ul:focus{outline:0}h1{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}h1{letter-spacing:min(max(-.011715625rem,4vw),-.0390625rem)}.u-h3,h2{letter-spacing:-.011715625rem}h2{font-size:min(max(1.25rem,3.5vw),1.5rem);line-height:min(max(1.4rem,3.5vw),1.6rem)}.u-h3{font-size:min(max(1.125rem,3vw),1.25rem);margin-bottom:8px}.u-h3,h2{font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}h3{font-size:min(max(1.125rem,3vw),1.25rem)}h3{font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;letter-spacing:-.011715625rem;line-height:1.4rem}[contenteditable]:focus,[tabindex="0"]:focus,a:focus,button:focus,input:focus,select:focus{outline:3px solid #fece3e;will-change:transform}body,button,div,form,h1,h2,h3,input{margin:0;padding:0}p{padding:0}a:hover{-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:active,button:active{outline:0}nav ol{list-style-image:none}body{font-size:1.125rem}p{margin:0 0 28px}ol,ul{margin-top:0;margin-bottom:28px}p:empty{display:none}.article-page{background:#fff}.composite-layer{transform:translateZ(0)}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1rem;line-height:1.3;display:flex;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{font-size:1rem;display:inline;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}@media only screen and (max-width:539px){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;line-height:1.3;font-size:1rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-author-affiliation__list,.c-article-author-information__list,.c-article-further-reading__list,.c-article-references{list-style:none;padding:0}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px;margin:0}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{padding-top:8px;margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__pill-button{padding:8px 16px 8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:.875rem;line-height:1.4;font-weight:700;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-decoration:none;display:inline-block}.c-article__pill-button:hover{background-color:#069;color:#fff;text-decoration:none}.c-article__pill-button:focus{outline:0;box-shadow:0 0 0 3px #fece3e;text-decoration:none}.c-article__pill-button:active,.c-article__pill-button:hover{box-shadow:0 0 0 0}.c-article__pill-button svg{width:auto;height:100%}.c-article__sub-heading{font-size:1.125rem;font-weight:400;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-style:normal;line-height:1.3;color:#222;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article-references__item{display:flex;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item::before{content:attr(data-counter);font-size:1.5rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__item::before{font-size:1.125rem;line-height:inherit}}.c-article-references__item>p.c-article-references__text{flex:1;padding-left:8px}.c-article-references__text{margin-bottom:8px}.c-article-references__links{display:flex;flex-basis:100%;justify-content:flex-end;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links>a{padding-left:8px}.c-article-references__links>a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-references__download svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-author-information__list{margin-top:0;margin-bottom:24px}.c-article-author-information__item{margin-bottom:16px}.c-article-author-information__subtitle{font-weight:700}.c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-author-affiliation__authors-list{padding:0;list-style:none;margin-bottom:16px;margin-top:0}.c-article-supplementary__item{margin-bottom:24px;position:relative}.c-article-supplementary__title{margin:0 0 8px;line-height:1.5}.c-article-further-reading__list{margin:0}.c-article-further-reading__item{border-bottom:1px solid #d5d5d5;margin-bottom:16px;position:relative}.c-article-further-reading__item:last-child{border:0}.c-article-further-reading__title{margin:0;padding:0;line-height:1.5}.c-article-further-reading__journal-title{color:#626262;font-size:.813rem;padding:0;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-further-reading__journal-title{margin-bottom:24px}.c-article-subject-list{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;list-style:none;display:flex;flex-wrap:wrap;padding:0;margin:0 0 24px}.c-article-subject-list__subject{background-color:#dae5ea;border-radius:20px;padding:4px 10px;font-weight:700;margin-right:15px;margin-bottom:16px;flex:0 1 auto}.c-bibliographic-information{display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1rem;display:block}.c-bibliographic-information__column:first-child{width:81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:flex;justify-content:flex-start;flex-wrap:wrap}.c-bibliographic-information__list-item{flex:0 0 33%;box-sizing:border-box;padding-right:8px;margin-bottom:16px;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{flex:0 0 100%}}.c-bibliographic-information__list-item p{margin-bottom:0}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;margin-bottom:8px}.c-bibliographic-information__download-citation{margin-bottom:24px}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-share-box__description{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:8px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem;margin-bottom:24px}.c-article-share-box__button{background:#fff;border:1px solid #069;box-sizing:content-box;color:#069;font-size:1rem;line-height:1.5;margin-bottom:8px;padding:8px 20px;text-align:center}@supports ((-webkit-backdrop-filter:blur(10px)) or (backdrop-filter:blur(10px))){.c-context-bar--sticky:after{background:linear-gradient(to top,rgba(255,255,255,.75) 50%,#fff);-webkit-backdrop-filter:blur(10px);backdrop-filter:blur(10px)}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0;min-height:200px}.c-reading-companion__tabs{font-size:1rem;list-style:none;display:flex;flex-direction:row;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{color:#069;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1.5;overflow:hidden;white-space:nowrap;text-overflow:ellipsis}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;color:#222}.c-header__menu--global .c-header__item svg{display:none}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-table{border:2px solid #d5d5d5;clear:both;padding:20px 10px;margin-bottom:24px}.c-article-table__figcaption{line-height:1.4;margin-bottom:16px;word-break:break-word}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1;padding:13px 24px!important}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:.875rem}}a:hover{text-decoration:underline;text-decoration-thickness:.3875rem;text-underline-offset:.08em}p{word-wrap:break-word;overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{display:none;background-color:#ccc}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 4px + 90px)}@media only screen and (min-width:768px){.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{display:none;background-color:transparent;padding:0}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 4px + 250px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad__label{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-ad__label{font-size:.875rem;font-weight:400;margin-bottom:4px;color:#333;line-height:1.5}.c-author-list{list-style:none;margin:0;padding:0;font-family:inherit;color:#6f6f6f}.c-author-list>li,.c-breadcrumbs>li,.js .c-author-list{display:inline}.c-author-list>li:not(:first-child):not(:last-child)::before{content:", "}.c-author-list>li:not(:only-child):last-child::before{content:" & "}.c-author-list--compact{line-height:1.4;font-size:.875rem}.c-author-list--truncated>li:not(:only-child):last-child::before{content:" ... "}.c-meta{list-style:none;padding:0;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:.875rem;color:inherit;line-height:1.4}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;padding-right:4px;margin-right:4px}.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;position:absolute}.c-skip-link{background:#069;color:#fff;font-size:.875rem;text-align:center;padding:8px;inset:0;bottom:auto;z-index:9999;transform:translateY(-100%)}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#fff}.c-skip-link:focus{transform:translateY(0)}.c-breadcrumbs{list-style:none;margin:0;padding:0;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;color:#000}.c-breadcrumbs__link,.c-breadcrumbs__link:hover,.c-breadcrumbs__link:visited{color:#666}.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0;aspect-ratio:var(--card--image-aspect-ratio, 16/9)}}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{width:100%;height:100%;transform:unset;-o-object-fit:cover;object-fit:cover}}.c-corporate-footer{background-color:#222;border-top:none;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;padding-top:16px;padding-bottom:24px}.c-corporate-footer__legal{color:#a2a2a2;font-size:.813rem;margin-bottom:0;padding-top:4px}.c-menu{list-style:none;margin:0;padding:0;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;display:flex;line-height:1.3}.c-menu__item:not(:last-child){margin-right:16px}.c-menu__link{display:inline-block}.c-menu__link:active,.c-menu__link:visited{color:inherit}.c-menu__link:hover{text-decoration:underline}.c-menu--inherit .c-menu__link,.c-menu--inherit .c-menu__link:hover,.c-menu--inherit .c-menu__link:visited{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;margin-bottom:16px;line-height:1.4}.c-header__row{position:relative;padding:8px 0}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__row--flush{padding:0}.c-header__split{display:flex;align-items:center;justify-content:space-between}.c-header__logo-container{flex:1 1 0;margin-right:24px;line-height:0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header__menu{list-style:none;padding:0;display:flex;align-items:center;flex-wrap:wrap;flex:0 1 auto;font-weight:700;line-height:1.4;margin:0 -8px}.c-header__menu--global{font-weight:400;justify-content:flex-end}@media only screen and (min-width:540px){.c-header__menu--global .c-header__item svg{display:block}}.c-header__menu--journal{font-size:.875rem}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}@media only screen and (max-width:1023px){.c-header__menu--tools{display:none}}.c-header__item{display:flex}@media only screen and (min-width:540px){.c-header__item:not(:first-child){margin-left:8px}}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}@media only screen and (max-width:767px){.c-header__item--nature-research{display:none}}.c-header__row--flush .c-header__item{padding-top:8px;padding-bottom:8px}.c-header__link{color:inherit;padding:8px;display:flex;align-items:center;white-space:nowrap}.c-header-expander a,.c-header-expander a.hover,.c-header-expander a.visited,.c-header-expander a:hover,.c-header-expander a:visited,.c-header__link.hover,.c-header__link.visited,.c-header__link:hover,.c-header__link:visited{color:inherit}.c-header__link ::first-letter{text-transform:capitalize}.c-header__link>svg{margin-left:2px;transition-duration:.2s}@media only screen and (min-width:540px){.c-header__link>svg{margin-left:4px}}.c-header__show-text{display:none}@media only screen and (min-width:540px){.c-header__show-text{display:inline}}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}.c-footer a,.c-footer a:hover,.c-footer a:visited{color:inherit}.c-footer{background-color:#2f2f2f;color:#d5d5d5;line-height:1.4;padding:24px 0;font-size:.875rem}.c-footer a{vertical-align:middle}.c-footer__header{margin-bottom:24px;padding-bottom:24px;border-bottom:1px solid #555}@media only screen and (min-width:768px){.c-footer__header{display:flex;align-items:center}}@media only screen and (max-width:767px){.c-footer__header>:not(:last-child){margin-bottom:16px}}@media only screen and (min-width:768px){.c-footer__logo{flex:1}}.c-footer__list{list-style:none;margin:0;padding:0}.c-footer__grid{display:flex;flex-wrap:wrap}@supports (display:grid){.c-footer__grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(250px,1fr));grid-column-gap:16px;grid-row-gap:32px}}.c-footer__group{flex:1 1 50%;max-width:50%;padding-right:16px;margin-bottom:16px}@media only screen and (min-width:1024px){.c-footer__group{flex-basis:25%;max-width:25%}}@supports (display:grid){.c-footer__group{padding-right:0;max-width:none;margin-bottom:0}}.c-footer__heading{color:#eee;margin-bottom:16px;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-footer__item:not(:last-child){margin-bottom:4px}.u-button svg{fill:currentColor}.u-button{text-decoration:none}.u-button{align-items:center;cursor:pointer;margin:0;position:relative;font-family:sans-serif;font-size:1rem;line-height:1.3;padding:8px;transition:.25s ease,color .25s ease,border-color .25s ease;border-radius:2px}.u-button,.u-button:visited{color:#069}.u-button,.u-button:hover{border:1px solid #069}.u-button:focus{border:1px solid #069}.u-button:focus,.u-button:hover{color:#fff;background-color:#069;background-image:none}.u-button--primary{color:#fff;background-color:#069;background-image:none}.u-button--primary:visited{color:#fff}.u-button--primary,.u-button--primary:hover{border:1px solid #069}.u-button--primary:focus{border:1px solid #069}.u-button--primary:focus,.u-button--primary:hover{color:#069;background-color:#fff;background-image:none}.u-button--disabled,.u-button:disabled{color:#222;background-color:transparent;background-image:none;border:1px solid #eee;opacity:.7;cursor:default}.u-button--disabled svg,.u-button:disabled svg{fill:currentColor}.u-button--disabled:visited,.u-button:disabled:visited{color:#222}.u-button--disabled:hover,.u-button:disabled:hover{border:1px solid #eee;text-decoration:none}.u-button--disabled:focus,.u-button:disabled:focus{border:1px solid #eee;text-decoration:none}.u-button--disabled:focus,.u-button--disabled:hover,.u-button:disabled:focus,.u-button:disabled:hover{color:#222;background-color:transparent;background-image:none}.u-button--full-width{display:flex;width:100%}.u-hide{display:none;visibility:hidden}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:768px){.u-show-at-md{display:block;visibility:visible}}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-float-left{float:left}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-right{text-align:right}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-inline{display:inline}.u-display-flex{display:flex;width:100%}.u-flex-wrap{flex-wrap:wrap}.u-justify-content-space-between{justify-content:space-between}.u-flex-shrink{flex:0 1 auto}.u-ma-0{margin:0}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mt-auto{margin-top:auto}.u-mr-2{margin-right:2px}.u-mr-32{margin-right:32px}.u-mb-4{margin-bottom:4px}.u-mb-16{margin-bottom:16px}.u-mb-32{margin-bottom:32px}html *,html ::after,html ::before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-footer a,.c-header__link{text-decoration:inherit}.c-footer a:hover,.c-header__link:hover,.c-site-messages .c-site-messages__close:hover,.nature-briefing-banner__checkbox-label a:hover{text-decoration:underline}.c-site-messages .c-site-messages__close{background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg%20width%3D'21'%20height%3D'21'%20xmlns%3D'http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg'%20aria-labelledby%3D'close'%20role%3D'img'%3E%3Ctitle%20id%3D'title'%3EClose%20button%20icon%3C%2Ftitle%3E%3Cpath%20d%3D'M10.5%2012.621l2.727%202.727%201.06%201.06%202.122-2.12-1.06-1.061L12.62%2010.5l2.727-2.727%201.06-1.06-2.12-2.122-1.061%201.06L10.5%208.38l-2.69-2.69-1.06-1.06L4.629%206.75l1.06%201.06%202.69%202.69-2.69%202.69-1.06%201.06%202.121%202.121%201.06-1.06%202.69-2.69zm0%208.379C4.701%2021%200%2016.299%200%2010.5S4.701%200%2010.5%200%2021%204.701%2021%2010.5%2016.299%2021%2010.5%2021z'%20fill%3D'%23fff'%20fill-rule%3D'evenodd'%2F%3E%3C%2Fsvg%3E"),none;background-position:100% 50%;background-repeat:no-repeat;background-size:16px}.c-site-messages--nature-briefing-email-variant{padding-top:15px;padding-bottom:15px;box-sizing:border-box}.c-site-messages--nature-briefing-email-variant .visually-hidden{width:1px;height:1px;position:absolute!important;clip:rect(1px,1px,1px,1px)}.c-site-messages--nature-briefing-email-variant .sans-serif,.c-site-messages--nature-briefing-email-variant.sans-serif{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-site-messages--nature-briefing-email-variant .box-sizing{box-sizing:border-box}.c-site-messages--nature-briefing-email-variant .text13{font-size:.8125rem}.c-site-messages--nature-briefing-email-variant .block{display:block}.c-site-messages--nature-briefing-email-variant .tighten-line-height{line-height:1.4}.c-site-messages--nature-briefing-email-variant .extra-tight-line-height{line-height:1.3}.c-site-messages--nature-briefing-email-variant .grid{float:left;padding-left:0!important;padding-right:0!important}.c-site-messages--nature-briefing-email-variant .grid{margin-right:3.2%}.c-site-messages--nature-briefing-email-variant .last{margin-right:0}.c-site-messages--nature-briefing-email-variant .grid-4{width:31.2%}.c-site-messages--nature-briefing-email-variant .grid-8{width:65.6%}.c-site-messages--nature-briefing-email-variant .grid-12{width:100%}.c-site-messages--nature-briefing{position:fixed;bottom:0;left:0;right:0;width:100%;box-shadow:0 0 10px 0 rgba(51,51,51,.2);transform:translateY(100%);border-bottom:none}.c-site-messages--nature-briefing .c-site-messages__close{border:0;padding-right:0}.c-site-messages--nature-briefing .c-site-messages__close-container{text-align:right;display:inline-block}.c-site-messages--nature-briefing .c-site-messages__close-container svg{width:25px;height:25px}.c-site-messages--nature-briefing.c-site-messages .c-site-messages__close{background:0 0}@media only screen and (min-width:960px){.c-site-messages--nature-briefing-email-variant.c-site-messages .c-site-messages__banner-large .c-site-messages__close{margin-top:0}}.c-site-messages__banner-large .c-site-messages__close-container{float:right;margin-top:-5px}.c-site-messages__banner-large .c-site-messages__form-container{float:none;width:100%}@media only screen and (min-width:768px){.c-site-messages__banner-large .c-site-messages__close-container{width:30px}.c-site-messages__banner-large .c-site-messages__form-container{float:left;width:calc(100% - 30px)}}.c-site-messages--nature-briefing .c-site-messages__close{vertical-align:top}.c-site-messages--is-visible .icon--inline path,.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages__close-container:hover .c-site-messages__close svg path{fill:#069}.c-site-messages--nature-briefing .c-site-messages__close{color:#069}.nature-briefing-banner__email-input{border-color:#222}.nature-briefing-banner__checkbox-label{cursor:pointer;position:relative;padding-left:33px;max-width:467px}.nature-briefing-banner__checkbox-label:before{content:"";position:absolute;top:6px;left:0;width:24px;height:24px;border:1px solid currentColor;border-radius:0;background:#fff}.nature-briefing-banner__checkbox-label:after{content:"";position:absolute;top:12px;left:5px;width:14px;height:7px;transform:rotate(-45deg);border:solid;border-width:0 0 2px 2px;border-top-color:transparent;opacity:0;background:0 0}.nature-briefing-banner__checkbox-checkbox{font-size:20px;cursor:pointer;position:absolute;z-index:1;top:4px;left:-2px;width:28px;height:28px;margin:0;opacity:0}.nature-briefing-banner__checkbox-checkbox:checked+.nature-briefing-banner__checkbox-label:after{opacity:1}.nature-briefing-banner__checkbox-checkbox:focus+.nature-briefing-banner__checkbox-label:before,.nature-briefing-banner__submit-button:focus{outline:3px solid #fece3e}.nature-briefing-banner__submit-button{background:#069;color:#fff;text-align:center}.nature-briefing-banner__submit-button:disabled{background-color:#777;color:#fff}.nature-briefing-banner__checkbox-label a{transition:color 1s ease-in-out 1s}.c-site-messages__banner-large{margin:0 auto;padding-left:16px;padding-right:16px}.c-site-messages__banner-large{display:none;max-width:1280px}.c-site-messages__banner-large:after,.c-site-messages__banner-large:before{content:" ";display:table}.c-site-messages__banner-large:after{clear:both}@media only screen and (min-width:641px){.c-site-messages__banner-large{display:block}}.c-site-messages.c-site-messages--nature-briefing-redesign-2020{color:#fff;background-color:#29303b;background-repeat:no-repeat;background-position:right top;background-image:url(data:image/png;base64,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);transition:transform .6s ease-in-out;padding-right:120px}@media only screen and (max-width:1040px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020{background-position:666px 0}}@media only screen and (max-width:870px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020{background-position:calc(85% + 374px - 120px) 0;padding-right:15%}}@media only screen and (max-width:640px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020{background-position:calc(100% + 374px - 200px) 0;padding-right:100px}}@media only screen and (max-width:480px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020{background-image:none;padding-right:0}}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages__close-container{width:25px;height:25px;position:absolute;right:10px;top:10px;background:#29303b;border-radius:12.5px;border:0}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages__close-container:hover{background:#fff}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages--nature-briefing__strapline{margin-top:10px;margin-bottom:0;font-size:.875rem}@media only screen and (min-width:1040px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages--nature-briefing__strapline{font-size:1rem}}@media only screen and (min-width:1200px){.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .c-site-messages--nature-briefing__strapline{font-size:1.125rem}}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__checkbox-label:before{border-color:transparent;border-radius:2px}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__checkbox-label:after{border-color:transparent #222 #222}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__checkbox-label a{font-weight:400;text-decoration:underline;color:#fff}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__email-label{display:block;padding-left:0}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__email-wrapper{margin-bottom:10px}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__email-input{display:inline-block;float:none;width:70%;max-width:500px;border:1px solid #fff;border-radius:2px;padding:8px 10px 7px;font-size:.9375rem;line-height:.9375rem;vertical-align:top;margin-right:1%}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__submit-button{display:inline-block;float:none;transition:none;background-color:#29303b;border-radius:2px;border:1px solid #fff;padding:8px 2%;font-size:.9375rem;line-height:.9375rem;vertical-align:top;width:15%;min-width:75px;max-width:90px}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__submit-button:hover,.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing__link:hover{color:#29303b;background-color:#fff}.c-site-messages.c-site-messages--nature-briefing-redesign-2020 .nature-briefing-banner__checkbox-wrapper{position:relative}.grade-c-hide{display:block}.c-site-messages--nature-briefing{z-index:100001}.u-lazy-ad-wrapper{min-height:137px;display:none;background-color:#ccc}@media only screen and (min-width:768px){.u-lazy-ad-wrapper{display:block}}</style>
<noscript>
                    <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-c2e8e04715.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
                </noscript>
<meta name=msapplication-TileColor content=#000000>
<meta name=msapplication-config content=/static/browserconfig.xml>
<meta name=theme-color content=#000000>
<meta name=application-name content=Nature>
<meta name=robots content=noarchive>
<meta name=access content=Yes>
<link rel=search href=http://www.nature.com/search>
<link rel=search href=http://www.nature.com/opensearch/opensearch.xml type=application/opensearchdescription+xml title=nature.com>
<link rel=search href=http://www.nature.com/opensearch/request type=application/sru+xml title=nature.com>
<script type=application/ld+json>{"mainEntity":{"headline":"TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19","description":"Among children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are typically mild. Here, we describe the case of a 3.5-year-old girl with an unusually severe presentation of coronavirus disease (COVID-19). The child had an autoinflammatory disorder of unknown etiology, which had been treated using prednisolone and methotrexate, and her parents were half cousins of Turkish descent. After 5 days of nonspecific viral infection symptoms, tonic-clonic seizures occurred followed by acute cardiac insufficiency, multi-organ insufficiency, and ultimate death. Trio exome sequencing identified a homozygous splice-variant in the gene TBK1, and a homozygous missense variant in the gene TNFRSF13B. Heterozygous deleterious variants in the TBK1 gene have been associated with severe COVID-19, and the variant in the TNFRSF13B gene has been associated with common variable immunodeficiency (CVID). We suggest that the identified variants, the autoinflammatory disorder and its treatment, or a combination of these factors probably predisposed to lethal COVID-19 in the present case.","datePublished":"2021-07-01","dateModified":"2021-07-01","pageStart":"1","pageEnd":"5","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41525-021-00220-w","keywords":"Autoinflammatory syndrome,Genetic testing,Infection,Viral infection,Biomedicine,general,Human Genetics,Internal Medicine,Bioinformatics,Gene Therapy,Gene Function","image":"","isPartOf":{"name":"npj Genomic Medicine","issn":["2056-7944"],"volumeNumber":"6","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group UK","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Schmidt, Axel","url":"http://orcid.org/0000-0002-9780-7243","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Peters, Sophia","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Knaus, Alexej","url":"http://orcid.org/0000-0003-0366-0533","affiliation":[{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn","address":{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sabir, Hemmen","affiliation":[{"name":"University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hamsen, Frauke","affiliation":[{"name":"University of Duisburg-Essen","address":{"name":"Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Maj, Carlo","affiliation":[{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn","address":{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Fazaal, Julia","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sivalingam, Sugirthan","url":"http://orcid.org/0000-0001-5239-5137","affiliation":[{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn","address":{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn","address":{"name":"Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Bonn","address":{"name":"Core Unit for Bioinformatics Data Analysis, Medical Faculty, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Savchenko, Oleksandr","affiliation":[{"name":"University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Department of Diagnostic and Interventional Radiology, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mantri, Aakash","url":"http://orcid.org/0000-0001-6763-5674","affiliation":[{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn","address":{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Holzinger, Dirk","url":"http://orcid.org/0000-0002-8062-8820","affiliation":[{"name":"University of Duisburg-Essen","address":{"name":"Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Neudorf, Ulrich","affiliation":[{"name":"University of Duisburg-Essen","address":{"name":"Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Müller, Andreas","affiliation":[{"name":"University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ludwig, Kerstin U.","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Krawitz, Peter M.","url":"http://orcid.org/0000-0002-3194-8625","affiliation":[{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn","address":{"name":"Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Engels, Hartmut","url":"http://orcid.org/0000-0003-1007-1809","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Nöthen, Markus M.","url":"http://orcid.org/0000-0002-8770-2464","affiliation":[{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"email":"markus.noethen@uni-bonn.de","@type":"Person"},{"name":"Bagci, Soyhan","affiliation":[{"name":"University of Bonn, School of Medicine & University Hospital Bonn","address":{"name":"Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>
<link rel=canonical href=https://www.nature.com/articles/s41525-021-00220-w>
<meta name=journal_id content=41525>
<meta name=dc.title content="TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19">
<meta name=dc.source content="npj Genomic Medicine 2021 6:1">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="Nature Publishing Group">
<meta name=dc.date content=2021-07-01>
<meta name=dc.type content=OriginalPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2021 The Author(s)">
<meta name=dc.rights content="2021 The Author(s)">
<meta name=dc.rightsAgent content=journalpermissions@springernature.com>
<meta name=dc.description content="Among children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are typically mild. Here, we describe the case of a 3.5-year-old girl with an unusually severe presentation of coronavirus disease (COVID-19). The child had an autoinflammatory disorder of unknown etiology, which had been treated using prednisolone and methotrexate, and her parents were half cousins of Turkish descent. After 5 days of nonspecific viral infection symptoms, tonic-clonic seizures occurred followed by acute cardiac insufficiency, multi-organ insufficiency, and ultimate death. Trio exome sequencing identified a homozygous splice-variant in the gene TBK1, and a homozygous missense variant in the gene TNFRSF13B. Heterozygous deleterious variants in the TBK1 gene have been associated with severe COVID-19, and the variant in the TNFRSF13B gene has been associated with common variable immunodeficiency (CVID). We suggest that the identified variants, the autoinflammatory disorder and its treatment, or a combination of these factors probably predisposed to lethal COVID-19 in the present case.">
<meta name=prism.issn content=2056-7944>
<meta name=prism.publicationName content="npj Genomic Medicine">
<meta name=prism.publicationDate content=2021-07-01>
<meta name=prism.volume content=6>
<meta name=prism.number content=1>
<meta name=prism.section content=OriginalPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=5>
<meta name=prism.copyright content="2021 The Author(s)">
<meta name=prism.rightsAgent content=journalpermissions@springernature.com>
<meta name=prism.url content=https://www.nature.com/articles/s41525-021-00220-w>
<meta name=prism.doi content=doi:10.1038/s41525-021-00220-w>
<meta name=citation_pdf_url content=https://www.nature.com/articles/s41525-021-00220-w.pdf>
<meta name=citation_fulltext_html_url content=https://www.nature.com/articles/s41525-021-00220-w>
<meta name=citation_journal_title content="npj Genomic Medicine">
<meta name=citation_journal_abbrev content="npj Genom. Med.">
<meta name=citation_publisher content="Nature Publishing Group">
<meta name=citation_issn content=2056-7944>
<meta name=citation_title content="TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19">
<meta name=citation_volume content=6>
<meta name=citation_issue content=1>
<meta name=citation_online_date content=2021/07/01>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=5>
<meta name=citation_article_type content="Case Report">
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1038/s41525-021-00220-w>
<meta name=DOI content=10.1038/s41525-021-00220-w>
<meta name=citation_doi content=10.1038/s41525-021-00220-w>
<meta name=citation_springer_api_url content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41525-021-00220-w&amp;api_key=">
<meta name=description content="Among children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are typically mild. Here, we describe the case of a 3.5-year-old girl with an unusually severe presentation of coronavirus disease (COVID-19). The child had an autoinflammatory disorder of unknown etiology, which had been treated using prednisolone and methotrexate, and her parents were half cousins of Turkish descent. After 5 days of nonspecific viral infection symptoms, tonic-clonic seizures occurred followed by acute cardiac insufficiency, multi-organ insufficiency, and ultimate death. Trio exome sequencing identified a homozygous splice-variant in the gene TBK1, and a homozygous missense variant in the gene TNFRSF13B. Heterozygous deleterious variants in the TBK1 gene have been associated with severe COVID-19, and the variant in the TNFRSF13B gene has been associated with common variable immunodeficiency (CVID). We suggest that the identified variants, the autoinflammatory disorder and its treatment, or a combination of these factors probably predisposed to lethal COVID-19 in the present case.">
<meta name=dc.creator content="Schmidt, Axel">
<meta name=dc.creator content="Peters, Sophia">
<meta name=dc.creator content="Knaus, Alexej">
<meta name=dc.creator content="Sabir, Hemmen">
<meta name=dc.creator content="Hamsen, Frauke">
<meta name=dc.creator content="Maj, Carlo">
<meta name=dc.creator content="Fazaal, Julia">
<meta name=dc.creator content="Sivalingam, Sugirthan">
<meta name=dc.creator content="Savchenko, Oleksandr">
<meta name=dc.creator content="Mantri, Aakash">
<meta name=dc.creator content="Holzinger, Dirk">
<meta name=dc.creator content="Neudorf, Ulrich">
<meta name=dc.creator content="Müller, Andreas">
<meta name=dc.creator content="Ludwig, Kerstin U.">
<meta name=dc.creator content="Krawitz, Peter M.">
<meta name=dc.creator content="Engels, Hartmut">
<meta name=dc.creator content="Nöthen, Markus M.">
<meta name=dc.creator content="Bagci, Soyhan">
<meta name=dc.subject content="Autoinflammatory syndrome">
<meta name=dc.subject content="Genetic testing">
<meta name=dc.subject content=Infection>
<meta name=dc.subject content="Viral infection">
<meta name=citation_reference content="CDC COVID-19 Response Team. Coronavirus disease 2019 in Children - United States, February 12-April 2, 2020. Morb. Mortal. Wkly. Rep. 69, 422–426 (2020).">
<meta name=citation_reference content="citation_journal_title=Lancet Child Adolesc. Health; citation_title=Children and young people remain at low risk of COVID-19 mortality; citation_author=SS Bhopal, J Bagaria, B Olabi, R Bhopal; citation_volume=5; citation_publication_date=2021; citation_pages=e12-e13; citation_doi=10.1016/S2352-4642(21)00066-3; citation_id=CR2">
<meta name=citation_reference content="Bixler, D. et al. SARS-CoV-2-associated deaths among persons aged <21 years - United States, February 12-July 31, 2020. Morb. Mortal. Wkly. Rep. 69, 1324–1329 (2020).">
<meta name=citation_reference content="citation_journal_title=Science; citation_title=Inborn errors of type I IFN immunity in patients with life-threatening COVID-19; citation_author=Q Zhang; citation_volume=370; citation_publication_date=2020; citation_pages=eabd4570; citation_doi=10.1126/science.abd4570; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Presence of genetic variants among young men with severe COVID-19; citation_author=CI van der Made; citation_volume=324; citation_publication_date=2020; citation_pages=663-673; citation_doi=10.1001/jama.2020.13719; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=eLife; citation_title=Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study; citation_author=C Fallerini; citation_volume=10; citation_publication_date=2021; citation_pages=e67569; citation_doi=10.7554/eLife.67569; citation_id=CR6">
<meta name=citation_reference content="Solanich, X. et al. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series. Preprint at 
                  https://www.medrxiv.org/content/10.1101/2021.03.14.21252289v1
                  
                 (2021).">
<meta name=citation_reference content="citation_journal_title=PloS ONE; citation_title=Functional dissection of the TBK1 molecular network; citation_author=A Goncalves; citation_volume=6; citation_publication_date=2011; citation_pages=e23971; citation_doi=10.1371/journal.pone.0023971; citation_id=CR8">
<meta name=citation_reference content="Povysil, G. et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J Clin Invest. (2021) (Epub ahead of print).">
<meta name=citation_reference content="Kosmicki, J. A. et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am J Hum Genet. (2021) (Epub ahead of print).">
<meta name=citation_reference content="citation_journal_title=Antivir. Res.; citation_title=Antiviral activities of type I interferons to SARS-CoV-2 infection; citation_author=E Mantlo, N Bukreyeva, J Maruyama, S Paessler, C Huang; citation_volume=179; citation_publication_date=2020; citation_pages=104811; citation_doi=10.1016/j.antiviral.2020.104811; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=Cell Rep.; citation_title=Evasion of type I interferon by SARS-CoV-2; citation_author=H Xia; citation_volume=33; citation_publication_date=2020; citation_pages=108234; citation_doi=10.1016/j.celrep.2020.108234; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=J. Exp. Med.; citation_title=The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection; citation_author=H Hemmi; citation_volume=199; citation_publication_date=2004; citation_pages=1641-1650; citation_doi=10.1084/jem.20040520; citation_id=CR13">
<meta name=citation_reference content="citation_journal_title=Rheumatol.; citation_title=Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline?; citation_author=C Kosukcu; citation_volume=60; citation_publication_date=2021; citation_pages=607-616; citation_doi=10.1093/rheumatology/keaa165; citation_id=CR14">
<meta name=citation_reference content="citation_journal_title=Nat. Genet.; citation_title=Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans; citation_author=U Salzer; citation_volume=37; citation_publication_date=2005; citation_pages=820-828; citation_doi=10.1038/ng1600; citation_id=CR15">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol.; citation_title=Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency; citation_author=AJ Fried, I Rauter, SR Dillon, HH Jabara, RS Geha; citation_volume=128; citation_publication_date=2011; citation_pages=226-228; citation_doi=10.1016/j.jaci.2011.01.048; citation_id=CR16">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol.; citation_title=TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes; citation_author=M Martinez-Gallo; citation_volume=131; citation_publication_date=2013; citation_pages=468-476; citation_doi=10.1016/j.jaci.2012.10.029; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol.; citation_title=The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency; citation_author=JJ Lee; citation_volume=126; citation_publication_date=2010; citation_pages=1234-1241; citation_doi=10.1016/j.jaci.2010.08.017; citation_id=CR18">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol.; citation_title=The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice; citation_author=C Bacchelli; citation_volume=127; citation_publication_date=2011; citation_pages=1253-1259; citation_doi=10.1016/j.jaci.2011.02.037; citation_id=CR19">
<meta name=citation_reference content="citation_journal_title=Ann. Allergy Asthma Immunol.; citation_title=Autoimmunity in common variable immunodeficiency; citation_author=S Agarwal, C Cunningham-Rundles; citation_volume=123; citation_publication_date=2019; citation_pages=454-460; citation_doi=10.1016/j.anai.2019.07.014; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=Blood; citation_title=Role of TNFRSF13B variants in patients with common variable immunodeficiency; citation_author=N Martínez-Pomar; citation_volume=114; citation_publication_date=2009; citation_pages=2846-2848; citation_doi=10.1182/blood-2009-05-213025; citation_id=CR21">
<meta name=citation_reference content="citation_journal_title=J. Clin. Immunol.; citation_title=Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI); citation_author=W Koopmans; citation_volume=33; citation_publication_date=2013; citation_pages=68-73; citation_doi=10.1007/s10875-012-9793-x; citation_id=CR22">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol.; citation_title=A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia; citation_author=I Quinti; citation_volume=146; citation_publication_date=2020; citation_pages=211-213; citation_doi=10.1016/j.jaci.2020.04.013; citation_id=CR23">
<meta name=citation_reference content="citation_journal_title=Ann. Allergy Asthma Immunol.; citation_title=The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019; citation_author=L Fill, L Hadney, K Graven, R Persaud, R Hostoffer; citation_volume=125; citation_publication_date=2020; citation_pages=112-114; citation_doi=10.1016/j.anai.2020.04.033; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Ann. Allergy Asthma Immunol.; citation_title=A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency; citation_author=J Mullur, A Wang, A Feldweg; citation_volume=126; citation_publication_date=2021; citation_pages=90-92; citation_doi=10.1016/j.anai.2020.08.017; citation_id=CR25">
<meta name=citation_reference content="citation_journal_title=J. Allergy Clin. Immunol. Pract.; citation_title=COVID-19 infection in 10 common variable immunodeficiency patients in New York City; citation_author=B Cohen; citation_volume=9; citation_publication_date=2021; citation_pages=504-507; citation_doi=10.1016/j.jaip.2020.11.006; citation_id=CR26">
<meta name=citation_reference content="citation_journal_title=Front. Immunol.; citation_title=Case report: convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19; citation_author=KFA Damme; citation_volume=11; citation_publication_date=2020; citation_pages=596761; citation_doi=10.3389/fimmu.2020.596761; citation_id=CR27">
<meta name=citation_reference content="Strangfeld, A. et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann. Rheum. Dis. (2021).">
<meta name=citation_reference content="citation_journal_title=Stroke; citation_title=Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association; citation_author=G Saposnik; citation_volume=42; citation_publication_date=2011; citation_pages=1158-1192; citation_doi=10.1161/STR.0b013e31820a8364; citation_id=CR29">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Hyperinflammatory shock in children during COVID-19 pandemic; citation_author=S Riphagen, X Gomez, C Gonzalez-Martinez, N Wilkinson, P Theocharis; citation_volume=395; citation_publication_date=2020; citation_pages=1607-1608; citation_doi=10.1016/S0140-6736(20)31094-1; citation_id=CR30">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19; citation_author=LR Feldstein; citation_volume=325; citation_publication_date=2021; citation_pages=1074-1087; citation_doi=10.1001/jama.2021.2091; citation_id=CR31">
<meta name=citation_reference content="citation_journal_title=Blood Adv.; citation_title=Reduced prevalence of SARS-CoV-2 infection in ABO blood group O; citation_author=MB Barnkob; citation_volume=4; citation_publication_date=2020; citation_pages=4990-4993; citation_doi=10.1182/bloodadvances.2020002657; citation_id=CR32">
<meta name=citation_author content="Schmidt, Axel">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Peters, Sophia">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Knaus, Alexej">
<meta name=citation_author_institution content="Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Sabir, Hemmen">
<meta name=citation_author_institution content="Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Hamsen, Frauke">
<meta name=citation_author_institution content="Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany">
<meta name=citation_author content="Maj, Carlo">
<meta name=citation_author_institution content="Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Fazaal, Julia">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Sivalingam, Sugirthan">
<meta name=citation_author_institution content="Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany">
<meta name=citation_author_institution content="Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany">
<meta name=citation_author_institution content="Core Unit for Bioinformatics Data Analysis, Medical Faculty, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Savchenko, Oleksandr">
<meta name=citation_author_institution content="Department of Diagnostic and Interventional Radiology, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Mantri, Aakash">
<meta name=citation_author_institution content="Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Holzinger, Dirk">
<meta name=citation_author_institution content="Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany">
<meta name=citation_author content="Neudorf, Ulrich">
<meta name=citation_author_institution content="Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany">
<meta name=citation_author content="Müller, Andreas">
<meta name=citation_author_institution content="Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Ludwig, Kerstin U.">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Krawitz, Peter M.">
<meta name=citation_author_institution content="Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Engels, Hartmut">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Nöthen, Markus M.">
<meta name=citation_author_institution content="Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=citation_author content="Bagci, Soyhan">
<meta name=citation_author_institution content="Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany">
<meta name=access_endpoint content=https://www.nature.com/platform/readcube-access>
<meta name=twitter:site content=@Nature_NPJ>
<meta name=twitter:card content=summary>
<meta name=twitter:title content="TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19">
<meta name=twitter:description content="npj Genomic Medicine - TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19">
<meta property=og:url content=https://www.nature.com/articles/s41525-021-00220-w>
<meta property=og:type content=article>
<meta property=og:site_name content=Nature>
<meta property=og:title content="TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19 - npj Genomic Medicine">
<meta http-equiv=origin-trial content="AzoawhTRDevLR66Y6MROu167EDncFPBvcKOaQispTo9ouEt5LvcBjnRFqiAByRT+2cDHG1Yj4dXwpLeIhc98/gIAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A6+nc62kbJgC46ypOwRsNW6RkDn2x7tgRh0wp7jb3DtFF7oEhu1hhm4rdZHZ6zXvnKZLlYcBlQUImC4d3kKihAcAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A/9La288e7MDEU2ifusFnMg1C2Ij6uoa/Z/ylwJIXSsWfK37oESIPbxbt4IU86OGqDEPnNVruUiMjfKo65H/CQwAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta itemprop=position content=1 class=sf-hidden><meta itemprop=position content=2 class=sf-hidden><meta itemprop=position content=3 class=sf-hidden><meta itemprop=position content=4 class=sf-hidden><meta itemprop=publisher content="Springer Nature" class=sf-hidden><link rel=icon type=image/png sizes=32x32 href="data:image/png;base64,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"><style>.sf-hidden{display:none!important}</style><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"></head>
<body class=article-page cz-shortcut-listen=true>
<noscript class=sf-hidden><iframe src="https://collect.nature.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<div class="position-relative cleared z-index-50 background-white" data-test=top-containers>
 <a class=c-skip-link href=#content>Skip to main content</a>
<div class="c-grade-c-banner u-hide sf-hidden">
 
</div>
 
 <div class=u-lazy-ad-wrapper>
 
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 <aside class="c-ad c-ad--728x90">
 <div class=c-ad__inner data-container-type=banner-advert>
 <p class=c-ad__label>Advertisement</p>
 
 
 
 <div id=div-gpt-ad-top-1 class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type=top data-pa11y-ignore data-gpt data-gpt-unitpath=/285/npjgenmed.nature.com/article data-gpt-sizes=728x90 data-gpt-targeting="type=article;pos=top;artid=s41525-021-00220-w;doi=10.1038/s41525-021-00220-w;subjmeta=1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699;kwrd=Autoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection">
 <noscript class=sf-hidden>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/npjgenmed.nature.com/article&amp;sz=728x90&amp;c=-754887965&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41525-021-00220-w%26doi%3D10.1038/s41525-021-00220-w%26subjmeta%3D1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699%26kwrd%3DAutoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/npjgenmed.nature.com/article&amp;sz=728x90&amp;c=-754887965&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41525-021-00220-w%26doi%3D10.1038/s41525-021-00220-w%26subjmeta%3D1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699%26kwrd%3DAutoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
 </div>
 
 
 </div>
 </aside>
 </div>
 <header class=c-header id=header data-header data-track-component=nature-150-split-header style=border-color:#e30613>
 <div class="c-header__row c-header__row--flush">
 <div class=c-header__container>
 <div class=c-header__split>
 
 
 <div class=c-header__logo-container>
 
 <a href=https://www.nature.com/npjgenmed data-track=click data-track-action=home data-track-label=image>
 <picture class=c-header__logo>
 
 <img src=data:image/svg+xml;base64,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 alt="npj Genomic Medicine" srcset sizes>
 </picture>
 </a>
 
 </div>
 
 <ul class="c-header__menu c-header__menu--global">
 <li class="c-header__item c-header__item--nature-research">
 <a class=c-header__link href=https://www.nature.com/siteindex data-test=siteindex-link data-track=click data-track-action="open nature research index" data-track-label=link>
 <span>View all journals</span>
 </a>
 </li>
 <li class="c-header__item c-header__item--pipe">
 <a class=c-header__link href=https://www.nature.com/articles/s41525-021-00220-w data-header-expander data-test=search-link data-track=click data-track-action="open search tray" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>Search</span><svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg>
 </a><div id=search-menu class="c-header-expander c-header-expander--tray u-hide-print has-tethered u-js-hide sf-hidden" data-track-component=nature-150-split-header hidden>
 
</div>
 </li>
 <li class=c-header__item>
 <a href=https://www.nature.com/nams/svc/myaccount id=my-account class="c-header__link placeholder" data-test=login-link data-track=click data-track-action="my account" data-track-category=nature-150-split-header data-track-label=link style=display:none>
 <svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill=#333 fill-rule=evenodd></path></svg>
</a>
<a href="https://idp.nature.com/authorize/natureuser?client_id=grover&amp;redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41525-021-00220-w" id=login-button class="c-header__link placeholder" data-test=login-link data-track=click data-track-action=login data-track-category=nature-150-split-header data-track-label=link>
 <span>Login</span><svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill=#333 fill-rule=evenodd></path></svg>
</a>
 </li>
 </ul>
 </div>
 </div>
 </div>
 
 <div class=c-header__row>
 <div class=c-header__container data-test=navigation-row>
 <div class=c-header__split>
 <div class=c-header__split>
 <ul class="c-header__menu c-header__menu--journal">
 
 <li class="c-header__item c-header__item--dropdown-menu" data-test=explore-content-button>
 <a href=https://www.nature.com/articles/s41525-021-00220-w class="c-header__link c-header__link--chevron" data-header-expander data-test=menu-button--explore data-track=click data-track-action="open explore expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span><span class=c-header__show-text>Explore</span> content</span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=Explore-content data-test=Explore-content id=explore data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 
 <li class="c-header__item c-header__item--dropdown-menu">
 <a href=https://www.nature.com/articles/s41525-021-00220-w class="c-header__link c-header__link--chevron" data-header-expander data-test=menu-button--about-the-journal data-track=click data-track-action="open about the journal expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>About <span class=c-header__show-text>the journal</span></span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=About-the-journal id=about-the-journal data-test=about-the-journal data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 <li class="c-header__item c-header__item--dropdown-menu u-mr-2" data-test=publish-with-us-button>
 <a href=https://www.nature.com/articles/s41525-021-00220-w class="c-header__link c-header__link--chevron c-header__link--dropdown-menu" data-header-expander data-test=menu-button--publish data-track=click data-track-action="open publish with us expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>Publish <span class=c-header__show-text>with us</span></span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=Publish-with-us-label id=publish-with-us data-test=publish-with-us data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 
 </ul>
 
 </div>
 <ul class="c-header__menu c-header__menu--tools">
 
 <li class=c-header__item>
 <a class=c-header__link href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=360" rel=nofollow data-track=click data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external>
 <span>Sign up for alerts</span><svg role=img aria-hidden=true focusable=false height=18 viewBox="0 0 18 18" width=18 xmlns=http://www.w3.org/2000/svg><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill=#222></path></svg>
 </a>
 </li>
 
 
 <li class="c-header__item c-header__item--pipe">
 <a class=c-header__link href=http://feeds.nature.com/npjgenmed/rss/current data-track=click data-track-action="rss feed" data-track-label=link>
 <span>RSS feed</span>
 </a>
 </li>
 
 </ul>
 </div>
 </div>
 </div>
 
 </header>
 
 
 <nav class="u-mb-16 u-hide u-show-at-md" aria-label=breadcrumbs>
 <div class=u-container>
 <ol class=c-breadcrumbs itemscope itemtype=https://schema.org/BreadcrumbList>
 <li class=c-breadcrumbs__item id=breadcrumb0 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href=https://www.nature.com/ itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label=link:nature><span itemprop=name>nature</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb1 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href=https://www.nature.com/npjgenmed itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label="link:npj genomic medicine"><span itemprop=name>npj genomic medicine</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb2 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href="https://www.nature.com/npjgenmed/articles?type=case-report" itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label="link:case reports"><span itemprop=name>case reports</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb3 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem>
 <span itemprop=name>article</span></li>
 </ol>
 </div>
 </nav>
 
 
</div>
<div class="u-container u-mt-32 u-mb-32 u-clearfix" id=content data-component=article-container data-container-type=article>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 
 <div class="c-context-bar u-hide sf-hidden" data-test=context-bar data-context-bar aria-hidden=true>
 
 </div>
 
 <article lang=en>
 
 <div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile sf-hidden">
 
 </div>
 
 <div class=c-article-header>
 <header>
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Case Report</li>
 
 
 <li class=c-article-identifiers__item>
 <span class=c-article-identifiers__open data-test=open-access>Open Access</span>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2021-07-01>01 July 2021</time></a></li>
 </ul>
 <h1 class=c-article-title data-test=article-title data-article-title><i>TBK1</i> and <i>TNFRSF13B</i> mutations and an autoinflammatory disease in a child with lethal COVID-19</h1>
 <ul class="c-article-author-list js-etal-collapsed js-no-scroll" data-etal=25 data-etal-small=3 data-test=authors-list data-component-authors-activator=authors-list><li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Axel-Schmidt aria-label="Read more about Axel Schmidt" data-author-popup=auth-Axel-Schmidt>Axel Schmidt</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup><sup class="u-js-hide sf-hidden">&nbsp;</sup>, <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Sophia-Peters aria-label="Read more about Sophia Peters" data-author-popup=auth-Sophia-Peters>Sophia Peters</a><sup class="u-js-hide sf-hidden"></sup><sup class="u-js-hide sf-hidden">&nbsp;</sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Alexej-Knaus aria-label="Read more about Alexej Knaus" data-author-popup=auth-Alexej-Knaus>Alexej Knaus</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup><sup class="u-js-hide sf-hidden">&nbsp;</sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Hemmen-Sabir aria-label="Read more about Hemmen Sabir" data-author-popup=auth-Hemmen-Sabir>Hemmen Sabir</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Frauke-Hamsen aria-label="Read more about Frauke Hamsen" data-author-popup=auth-Frauke-Hamsen>Frauke Hamsen</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Carlo-Maj aria-label="Read more about Carlo Maj" data-author-popup=auth-Carlo-Maj>Carlo Maj</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Julia-Fazaal aria-label="Read more about Julia Fazaal" data-author-popup=auth-Julia-Fazaal>Julia Fazaal</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Sugirthan-Sivalingam aria-label="Read more about Sugirthan Sivalingam" data-author-popup=auth-Sugirthan-Sivalingam>Sugirthan Sivalingam</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden">,,</sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Oleksandr-Savchenko aria-label="Read more about Oleksandr Savchenko" data-author-popup=auth-Oleksandr-Savchenko>Oleksandr Savchenko</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Aakash-Mantri aria-label="Read more about Aakash Mantri" data-author-popup=auth-Aakash-Mantri>Aakash Mantri</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Dirk-Holzinger aria-label="Read more about Dirk Holzinger" data-author-popup=auth-Dirk-Holzinger>Dirk Holzinger</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Ulrich-Neudorf aria-label="Read more about Ulrich Neudorf" data-author-popup=auth-Ulrich-Neudorf>Ulrich Neudorf</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Andreas-M_ller aria-label="Read more about Andreas Müller" data-author-popup=auth-Andreas-M_ller>Andreas Müller</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Kerstin_U_-Ludwig aria-label="Read more about Kerstin U. Ludwig" data-author-popup=auth-Kerstin_U_-Ludwig>Kerstin U. Ludwig</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Peter_M_-Krawitz aria-label="Read more about Peter M. Krawitz" data-author-popup=auth-Peter_M_-Krawitz>Peter M. Krawitz</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Hartmut-Engels aria-label="Read more about Hartmut Engels" data-author-popup=auth-Hartmut-Engels>Hartmut Engels</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__show-more u-js-hide js-small-screen-show-inline sf-hidden" aria-label="Show all 18 authors for this article" title="Show all 18 authors for this article">…<li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Markus_M_-N_then aria-label="Read more about Markus M. Nöthen" data-author-popup=auth-Markus_M_-N_then data-corresp-id=c1>Markus M. Nöthen<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup> &amp; <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Soyhan-Bagci aria-label="Read more about Soyhan Bagci" data-author-popup=auth-Soyhan-Bagci>Soyhan Bagci</a><sup class="u-js-hide sf-hidden"></sup>&nbsp;</ul><button aria-expanded=false class="c-button-author-list js-etal-show-more u-js-hide js-small-screen-show-inline sf-hidden"><svg aria-hidden=true width=16 height=16 focusable=false class=u-icon><use href=#icon-plus></use></svg></button>
 
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://www.nature.com/npjgenmed><i data-test=journal-title>npj Genomic Medicine</i></a>
 <b data-test=journal-volume><span class=u-visually-hidden>volume</span>&nbsp;6</b>, Article&nbsp;number:&nbsp;<span data-test=article-number>55</span> (<span data-test=article-publication-year>2021</span>)
 <a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>3464 <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>11 <span class=c-article-metrics-bar__label>Citations</span></p>
 </li>
 
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>306 <span class=c-article-metrics-bar__label>Altmetric</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://www.nature.com/articles/s41525-021-00220-w/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
 
 </header>
 
 
 
 
 
 
 </div>
 <div class=c-article-body>
 <section aria-labelledby=Abs1 data-title=Abstract data-gtm-vis-polling-id-50443292_562=120 data-gtm-vis-polling-id-50443292_563=122 data-gtm-vis-recent-on-screen-50443292_562=604 data-gtm-vis-first-on-screen-50443292_562=604 data-gtm-vis-total-visible-time-50443292_562=8800 data-gtm-vis-recent-on-screen-50443292_563=604 data-gtm-vis-first-on-screen-50443292_563=604 data-gtm-vis-total-visible-time-50443292_563=8800 lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><p>Among children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are typically mild. Here, we describe the case of a 3.5-year-old girl with an unusually severe presentation of coronavirus disease (COVID-19). The child had an autoinflammatory disorder of unknown etiology, which had been treated using prednisolone and methotrexate, and her parents were half cousins of Turkish descent. After 5 days of nonspecific viral infection symptoms, tonic-clonic seizures occurred followed by acute cardiac insufficiency, multi-organ insufficiency, and ultimate death. Trio exome sequencing identified a homozygous splice-variant in the gene <i>TBK1</i>, and a homozygous missense variant in the gene <i>TNFRSF13B</i>. Heterozygous deleterious variants in the <i>TBK1</i> gene have been associated with severe COVID-19, and the variant in the <i>TNFRSF13B</i> gene has been associated with common variable immunodeficiency (CVID). We suggest that the identified variants, the autoinflammatory disorder and its treatment, or a combination of these factors probably predisposed to lethal COVID-19 in the present case.</p></div></div></section>
 <noscript class=sf-hidden>
                
            </noscript>
 
 
 <section data-title=Introduction data-gtm-vis-polling-id-50443292_562=121 data-gtm-vis-polling-id-50443292_563=123 data-gtm-vis-recent-on-screen-50443292_562=604 data-gtm-vis-first-on-screen-50443292_562=604 data-gtm-vis-total-visible-time-50443292_562=8800 data-gtm-vis-recent-on-screen-50443292_563=604 data-gtm-vis-first-on-screen-50443292_563=604 data-gtm-vis-total-visible-time-50443292_563=8800><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Introduction</h2><div class=c-article-section__content id=Sec1-content><p>Coronavirus disease (COVID-19) is an infectious disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Among children, severe COVID-19 disease courses are rare, and mainly affect children with underlying medical conditions<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="CDC COVID-19 Response Team. Coronavirus disease 2019 in Children - United States, February 12-April 2, 2020. Morb. Mortal. Wkly. Rep. 69, 422–426 (2020)." href=#ref-CR1 id=ref-link-section-d7690178e630>1</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Bhopal, S. S., Bagaria, J., Olabi, B. &amp; Bhopal, R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc. Health 5, e12–e13 (2021)." href=#ref-CR2 id=ref-link-section-d7690178e630_1>2</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Bixler, D. et al. SARS-CoV-2-associated deaths among persons aged <21 years - United States, February 12-July 31, 2020. Morb. Mortal. Wkly. Rep. 69, 1324–1329 (2020)." href=#ref-CR3 id=ref-link-section-d7690178e633>3</a></sup>. Underlying medical conditions reported to date in children with severe COVID-19 include chronic lung disease, obesity, neurological and developmental disorders, and immunosupressed status<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Bixler, D. et al. SARS-CoV-2-associated deaths among persons aged <21 years - United States, February 12-July 31, 2020. Morb. Mortal. Wkly. Rep. 69, 1324–1329 (2020)." href=#ref-CR3 id=ref-link-section-d7690178e637>3</a></sup>.<p>Recent research in adult SARS-CoV-2 cases has identified associations between severe COVID-19 and several rare genetic variants in genes implicated in TLR3-, TLR7-, and IRF7-dependent IFN type I immunity, including heterozygous variants in the gene <i>TBK1</i><sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020)." href=#ref-CR4 id=ref-link-section-d7690178e646>4</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="van der Made, C. I. Presence of genetic variants among young men with severe COVID-19. JAMA 324, 663–673 (2020)." href=#ref-CR5 id=ref-link-section-d7690178e646_1>5</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fallerini, C. et al. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. eLife 10, e67569 (2021)." href=#ref-CR6 id=ref-link-section-d7690178e646_2>6</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Solanich, X. et al. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series. Preprint at 
                  https://www.medrxiv.org/content/10.1101/2021.03.14.21252289v1
                  
                 (2021)." href=#ref-CR7 id=ref-link-section-d7690178e649>7</a></sup>.<p>The present report describes the case of a 3.5-year-old girl with an unclassified autoinflammatory disease who died secondary to COVID-19. This severe COVID-19 disease course is unusual in a child of this age. We therefore suspected an underlying inborn disorder, and conducted trio exome sequencing. This identified one variant respectively in the genes <i>TBK1</i> and <i>TNFRSF13B</i>. These represent potential predisposing genetic factors for severe COVID-19, in the context of the unclassified autoinflammatory disease and its treatment regimen.</p></div></div></section><section data-title=Results><div class=c-article-section id=Sec2-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec2>Results</h2><div class=c-article-section__content id=Sec2-content><h3 class=c-article__sub-heading id=Sec3>Case report (for further details, see Supplementary Note)</h3><p>The 3.5-year-old girl was born to consanguineous parents (half cousins with one common grandfather) of Turkish descent. From the age of 6 months, the girl had had a history of an unclassified autoinflammatory disease, whose key features comprised chronic synovitis/polyarthritis, and recurrent episodes of exanthema and systemic inflammation. Immunodiagnostics (vaccination responses and immune status) had been unremarkable, and no recurrent infections had been observed. In the 10 months prior to death, the autoinflammatory disease had been treated with prednisolone (0.16 mg/kg per day) and methotrexate (12.5 mg/m²/week, last administration 3 days prior to hospital admission). The parents reported that for the 5 days prior to admission, the child had displayed nonspecific signs of infection (intermittent fever and ear pain). On day 5, the fever had subsided. However, the girl had become anxious, and visibly distressed by loud noises. Two hours later, the girl had displayed features of a tonic-clonic seizure, which stopped spontaneously after 5 min. The girl was then admitted to hospital, and diagnosed as being in an afebrile postictal state with signs of an acute upper airway infection. In the period 5 to 11 h post-admission, several tonic-clonic seizures occurred. Native emergency computed tomography (CT) and a lumbar puncture were then performed. The CT results were unremarkable. However, lumbar puncture revealed pleocytosis, increased levels of protein and lactate, and a normal glucose level. At 90 min post-lumbar puncture, acute heart failure occurred. After 15 min of cardiopulmonary resuscitation, sufficient cardiopulmonary function resumed. However, the girl remained unconscious. Instrumental diagnostics revealed evidence of cardiac insufficiency, diminished electrical activity of the brain, and bilateral pneumonic infiltrations. Laboratory diagnostics revealed disseminated intravascular coagulation, metabolic acidosis, and elevated levels of creatinine and transaminase. At this time-point, throat swabs were taken for SARS-CoV-2 testing. Two days after hospital admission, signs of multiorgan failure developed. A repeat cranial CT revealed signs compatible with a thrombosis of the dural sinus and venous infarction. A positive SARS-CoV-2 test result was then returned. Despite continued intensive care management, the girl died of multi-organ insufficiency 62 h post-hospital admission.<h3 class=c-article__sub-heading id=Sec4>Exome sequencing</h3><p>For a child, the girl experienced an unusually severe COVID-19 course. We therefore suspected an underlying inborn disorder, and performed trio exome sequencing. In total, we identified around 112,000 variants. Of these, 800 had allele frequencies below 2% and showed some evidence for deleteriousness (Table <a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a>). Further prioritization strategies focused on variants that: (1) were located in genes of potential relevance to the phenotype; and (2) segregated in compliance with a fully penetrant Mendelian disease model. Seven variants fulfilled both criteria (Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>). Of these, one homozygous variant in the genes <i>TBK1</i> and <i>TNFRSF13B</i>, respectively (see Table <a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>) were considered likely causal factors for the severe COVID-19 disease course observed in the present case.<div class=c-article-table data-test=inline-table data-container-section=table id=table-1><figure><figcaption class=c-article-table__figcaption><b id=Tab1 data-test=table-caption>Table 1 Variant filtering and analysis scheme.</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://www.nature.com/articles/s41525-021-00220-w/tables/1 aria-label="Full size table 1"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><div class=c-article-table data-test=inline-table data-container-section=table id=table-2><figure><figcaption class=c-article-table__figcaption><b id=Tab2 data-test=table-caption>Table 2 Potentially causative variants identified by exome sequencing.</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://www.nature.com/articles/s41525-021-00220-w/tables/2 aria-label="Full size table 2"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><h3 class=c-article__sub-heading id=Sec5>Homozygous variant in the <i>TBK1</i> gene</h3><p>In the <i>TBK1</i> gene, a homozygous deletion was identified near the exon-intron border between exon 16 and intron 16 (NM_013254.4:c.1760 + 4_1760 + 7del). Both parents carried the variant in a heterozygous state. Because of the low coverage in the exome data at this locus, this variant was confirmed in the patient DNA using Sanger sequencing (see Supplementary Fig. <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM1>1</a>). The variant altered the splice site by deleting four nucleotides (TAAgta<s>agta</s>tcc, capitalized bases in the exon, crossed-out bases deleted in the index patient). The effect of the variant on the transcriptional level is difficult to ascertain in silico. The deep learning-based tool spliceAI generated a high confidence prediction of a loss of the splice donor site (delta-score/estimated probability (<i>p</i>): 0.93; coordinates used for prediction: chr12:64890189AAGTA &gt; A/hg19). However, the software did not predict the possible location of a new splice donor site for this variant, and generated a low confidence level prediction (<i>p</i>: 0.06) that the original donor splice site is used. SpliceAI also predicted that complete skipping of the exon might be possible (<i>p</i>: 0.34 for a loss of the splice acceptor site of exon 16). This variant is reported in a heterozygous state in one individual in the population-based database gnomAD. However, it is not reported in any other population-based database, or in any phenotype-related database. MutationTaster (mutationtaster.org) classifies the variant as a polymorphism. In contrast, the combined annotation dependent depletion (CADD) score of this variant is 34, indicating that it ranks among the 0.1% most deleterious variants (version 1.4/<a href=https://cadd.gs.washington.edu/>https://cadd.gs.washington.edu</a>). Sequencing of <i>TBK1</i> cDNA from the heterozygous parents revealed the presence of an alternatively spliced <i>TBK1</i> transcript, in which exon 16 was skipped (r.1721_1760del, see Supplementary Fig. <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM1>1</a>). This is consistent with results from the in silico prediction by SpliceAI. At the protein level, skipping of exon 16 is predicted to result in a frameshift and a premature stop codon, which could result in a truncated TBK1 protein that is characterized by the absence of the entire coiled coiled domain 2 (CCD2) and the partial absence of CCD1 (p.(Arg574Serfs*11)).<h3 class=c-article__sub-heading id=Sec6>Homozygous variant in the <i>TNFRSF13B</i> gene</h3><p>In the gene <i>TNFRSF13B</i>, a homozygous missense variant was identified in exon 3 (NM_012452.2:c.310 T &gt; C;p.(Cys104Arg)). Both parents carried the variant in a heterozygous state. The allele frequency of this variant in population-based databases ranges up to 0.5% (gnomAD European population), and the variant is listed four times in gnomAD in a homozygous state (Table <a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>). Several mutation prediction programs (MutationTaster, SIFT/PROVEAN/provean.jcvi.org, and PolyPhen-2/genetics.bwh.harvard.edu/pph2/) classify the variant as pathogenic. The CADD score of the Cys104Arg variant is 26.1, indicating that it ranks among the 1% most deleterious variants.</p></div></div></section><section data-title=Discussion><div class=c-article-section id=Sec7-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec7>Discussion</h2><div class=c-article-section__content id=Sec7-content><p>The unusually severe and ultimately lethal COVID-19 disease course observed in the present preschool child suggested the presence of predisposing factors, such as an inborn error of immunity. In summary, we identified the following potential predisposing factors:<p>The homozygous variant in <i>TBK1</i> (NM_013254.4:c.1760 + 4_1760 + 7del) had a demonstrable effect on splicing (r.1721_1760del). Potentially, this variant could result in a truncated TBK1 protein (p.(Arg574Serfs*11)) that lacks parts of CCD1 and the entirety of CCD2. Research has shown that the deletion of CCD1 results in a dysfunctional TBK1 protein<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Goncalves, A. et al. Functional dissection of the TBK1 molecular network. PloS ONE 6, e23971 (2011)." href=#ref-CR8 id=ref-link-section-d7690178e1164>8</a></sup>. The <i>TBK1</i> gene is involved in the TLR3 and IRF7 dependent IFN type I pathway, in which an excess of deleterious variants—including two heterozygous <i>TBK1</i> mutations— has been associated with a severe COVID-19 disease course<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 4" title="Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020)." href=#ref-CR4 id=ref-link-section-d7690178e1174>4</a></sup>. However, available data on the role of the type I IFN pathway in COVID-19 severity are conflicting. While two recent preprints concerning exome-sequencing data failed to replicate the association between rare variants in this pathway and severe COVID-19<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Povysil, G. et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J Clin Invest. (2021) (Epub ahead of print)." href=#ref-CR9 id=ref-link-section-d7690178e1179>9</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Kosmicki, J. A. et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am J Hum Genet. (2021) (Epub ahead of print)." href=#ref-CR10 id=ref-link-section-d7690178e1182>10</a></sup>, three genetic studies have found an association between variants in the gene <i>TLR7</i>—which also activates type I IFN transcription—and a severe COVID-19 disease course<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="van der Made, C. I. Presence of genetic variants among young men with severe COVID-19. JAMA 324, 663–673 (2020)." href=#ref-CR5 id=ref-link-section-d7690178e1189>5</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fallerini, C. et al. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. eLife 10, e67569 (2021)." href=#ref-CR6 id=ref-link-section-d7690178e1189_1>6</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Solanich, X. et al. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series. Preprint at 
                  https://www.medrxiv.org/content/10.1101/2021.03.14.21252289v1
                  
                 (2021)." href=#ref-CR7 id=ref-link-section-d7690178e1192>7</a></sup>.<p>Type I IFNs display strong anti-SARS-CoV-2 activity in cultured cells<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S. &amp; Huang, C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antivir. Res. 179, 104811 (2020)." href=#ref-CR11 id=ref-link-section-d7690178e1199>11</a></sup>, and the virus itself inhibits numerous proteins of the innate IFN type I response<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Xia, H. et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020)." href=#ref-CR12 id=ref-link-section-d7690178e1203>12</a></sup>. Research in a murine knockout model demonstrated that TBK1 is important in terms of the interferon response of embryonic fibroblasts to events such as viral infections<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Hemmi, H. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199, 1641–1650 (2004)." href=#ref-CR13 id=ref-link-section-d7690178e1207>13</a></sup>.<p>A recent report suggested that a homozygous truncating variant of <i>TBK1</i>, c.1318 C &gt; T;p.(Arg440*), might have been the causal factor for an autoinflammatory disease in a preschool child. The girl had presented with a history of recurrent fever and erythematous rash, growth failure, and neurocognitive retardation<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Kosukcu, C. et al. Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline? Rheumatol. 60, 607–616 (2021)." href=#ref-CR14 id=ref-link-section-d7690178e1217>14</a></sup>.<p>Overall, a plausible hypothesis is that the present <i>TBK1</i> variant caused an untuned IFN type I response, which led in turn to a propensity to a severe COVID-19 disease course. Additionally, homozygous <i>TBK1</i> variants may cause an autoinflammatory disorder, as observed in both the present case and the previously reported preschool child. Further studies are warranted to elucidate the potential contribution of the <i>TBK1</i> variant to both the severe COVID-19 disease course, and the underlying autoinflammatory disorder, observed in the present case.<p>In <i>TNFRSF13B</i> we identified a homozygous missense variant (NM_012452.2:c.310 T &gt; C;p.(Cys104Arg)). Variants in the gene <i>TNFRSF13B</i> have been associated with the common variable immunodeficiency (CVID) syndrome “Common variable immune deficiency 2” (CVID2, OMIM # 240500), and the immunoglobulin A deficiency (IGAD) “Immunoglobulin A deficiency 2”/IGAD2 (OMIM # 609529). The present variant is listed several times in phenotype-related databases (ClinVar/ncbi.nlm.nih.gov/clinvar, HGMD/hgmd.cf.ac.uk, and LOVD/lovd.nl). Interpretations of its clinical significance diverge, and vary from probably benign to pathogenic with “likely pathogenic” or “pathogenic” as the most common interpretations. Functional studies have demonstrated that the variant has a damaging effect on protein function<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37, 820–828 (2005)." href=#ref-CR15 id=ref-link-section-d7690178e1243>15</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fried, A. J., Rauter, I., Dillon, S. R., Jabara, H. H. &amp; Geha, R. S. Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency. J. Allergy Clin. Immunol. 128, 226–228 (2011)." href=#ref-CR16 id=ref-link-section-d7690178e1243_1>16</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Martinez-Gallo, M. et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J. Allergy Clin. Immunol. 131, 468–476 (2013)." href=#ref-CR17 id=ref-link-section-d7690178e1246>17</a></sup>, and research has demonstrated B-cell dysfunction in mice that are transgenic for the murine homolog of the variant<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Lee, J. J. et al. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J. Allergy Clin. Immunol. 126, 1234–1241 (2010)." href=#ref-CR18 id=ref-link-section-d7690178e1250>18</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Bacchelli, C. et al. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. J. Allergy Clin. Immunol. 127, 1253–1259 (2011)." href=#ref-CR19 id=ref-link-section-d7690178e1253>19</a></sup>.<p>CVID is characterized by hypogammaglobulinemia, with decreased levels of IgG and a marked decrease in at least one of the isotypes IgM and IgA (<a href=https://esid.org/Education/Common-Variable-Immunodeficiency-CVI-diagnosis-criteria>https://esid.org/Education/Common-Variable-Immunodeficiency-CVI-diagnosis-criteria</a>). Splenomegaly, lymphoid hyperplasia, and autoimmune rheumatological diseases, such as juvenile forms of chronic inflammatory arthritis, may also occur<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Agarwal, S. &amp; Cunningham-Rundles, C. Autoimmunity in common variable immunodeficiency. Ann. Allergy Asthma Immunol. 123, 454–460 (2019)." href=#ref-CR20 id=ref-link-section-d7690178e1267>20</a></sup>. Research suggests that CVID2 could have both a recessive and a dominant mode of inheritance<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37, 820–828 (2005)." href=#ref-CR15 id=ref-link-section-d7690178e1271>15</a></sup>. Additionally, reduced penetrance and variable expressivity have been observed in homozygous carriers of the reported <i>TNFRSF13B</i> variant for CVID2. Some homozygous carriers are asymptomatic, or show immunological abnormalities that do not meet the clinical criteria for CVID<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Martinez-Gallo, M. et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J. Allergy Clin. Immunol. 131, 468–476 (2013)." href=#ref-CR17 id=ref-link-section-d7690178e1278>17</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Martínez-Pomar, N. et al. Role of TNFRSF13B variants in patients with common variable immunodeficiency. Blood 114, 2846–2848 (2009)." href=#ref-CR21 id=ref-link-section-d7690178e1281>21</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Koopmans, W. et al. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J. Clin. Immunol. 33, 68–73 (2013)." href=#ref-CR22 id=ref-link-section-d7690178e1284>22</a></sup>. The present patient did not fulfill the clinical criteria for CVID at disease onset, since she did not display hypogammaglobulinemia, had an intact vaccination response, and had no apparent history of recurrent infections. However, this may have been attributable to a reduced penetrance of the CVID-phenotype, which may have been age-related. A literature search revealed a total of 18 CVID patients with COVID-19, two of whom died<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Quinti, I. et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J. Allergy Clin. Immunol. 146, 211–213 (2020). e4." href=#ref-CR23 id=ref-link-section-d7690178e1289>23</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fill, L., Hadney, L., Graven, K., Persaud, R. &amp; Hostoffer, R. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019. Ann. Allergy Asthma Immunol. 125, 112–114 (2020)." href=#ref-CR24 id=ref-link-section-d7690178e1289_1>24</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Mullur, J., Wang, A. &amp; Feldweg, A. A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency. Ann. Allergy Asthma Immunol. 126, 90–92 (2021)." href=#ref-CR25 id=ref-link-section-d7690178e1289_2>25</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Cohen, B. et al. COVID-19 infection in 10 common variable immunodeficiency patients in New York City. J. Allergy Clin. Immunol. Pract. 9, 504–507 (2021)." href=#ref-CR26 id=ref-link-section-d7690178e1289_3>26</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="van Damme, K. F. A. et al. Case report: convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19. Front. Immunol. 11, 596761 (2020)." href=#ref-CR27 id=ref-link-section-d7690178e1292>27</a></sup>. The largest study of comorbid CVID/COVID-19 to date included ten patients. Due to the relatively mild disease course observed in all cases, the authors concluded that this population showed no increased risk for a severe COVID-19 disease course<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 26" title="Cohen, B. et al. COVID-19 infection in 10 common variable immunodeficiency patients in New York City. J. Allergy Clin. Immunol. Pract. 9, 504–507 (2021)." href=#ref-CR26 id=ref-link-section-d7690178e1296>26</a></sup>. In summary, the <i>TNFRSF13B</i>-variant may have contributed to the fulminant SARS-CoV-2 infection and to the nonspecific, preexisting autoinflammatory disease observed in the present case.<p>COVID-19 disease progression may have been exacerbated by the child’s preexisting unclassified autoinflammatory disease and treatment with prednisolone and methotrexate. A recent study analyzed 3729 patients with inflammatory rheumatic diseases<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 28" title="Strangfeld, A. et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann. Rheum. Dis. (2021)." href=#ref-CR28 id=ref-link-section-d7690178e1306>28</a></sup>, and found that the use of high dose glucocorticoids (≥10 mg/day; odds ratio (OR) 1.69) and high disease activity (OR 1.87) were associated with a higher probability of death secondary to COVID-19. In contrast, methotrexate monotherapy was associated with a lower probability of death compared to the absence of a disease-modifying anti-rheumatic drug (DMARD) treatment (OR 0.47). Therefore, the child’s prednisolone treatment (0.16 mg/kg per day) in particular may have promoted the severe COVID-19 disease course. However, the referenced study involved adult patients, and the issue of whether the findings can be generalized to pediatric populations remains unclear.<p>The rapid deterioration observed in the present case may have been attributable to complications of the SARS-CoV-2 infection, such as a dural sinus thrombosis which may have been overlooked by the primary non-contrast CT investigation<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 29" title="Saposnik, G. et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 1158–1192 (2011)." href=#ref-CR29 id=ref-link-section-d7690178e1313>29</a></sup>. Another potential complication may have been a SARS-CoV-2 infection of the central nervous system that escaped detection during CSF testing. The recently reported multisystem inflammatory syndrome in children (MIS-C) is another SARS-CoV-2 associated complication for which fatalities have been reported<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. &amp; Theocharis, P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395, 1607–1608 (2020)." href=#ref-CR30 id=ref-link-section-d7690178e1317>30</a></sup>. While we cannot exclude MIS-C the child did not display some of the typical symptoms of MIS-C, such as persistent pyrexia, gastrointestinal symptoms, and mucocutaneous involvement<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325, 1074–1087 (2021)." href=#ref-CR31 id=ref-link-section-d7690178e1321>31</a></sup>. Furthermore, the abrupt onset of severe COVID-19 symptoms during active infection is more suggestive of an immune deficiency than the hyperinflammation that is frequently seen in MIS-C<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325, 1074–1087 (2021)." href=#ref-CR31 id=ref-link-section-d7690178e1325>31</a></sup>. In addition, the child had blood group A, which is a reported risk factor for SARS-CoV-2 susceptibility<sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 32" title="Barnkob, M. B. et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv. 4, 4990–4993 (2020)." href=#ref-CR32 id=ref-link-section-d7690178e1329>32</a></sup>.<p>We describe three potential predisposing factors—a homozygous splice site mutation in <i>TBK1</i>, a deleterious missense mutation in <i>TNFRSF13B</i>, and the presence of an autoinflammatory disease and its treatment regimen—which might have promoted the severe disease course observed in the present case either alone or in concert. At writing, we are unable to assign the contribution of each factor with certainty. In our opinion, however, the currently available evidence favors the <i>TBK1</i> variant over the other two factors as a driver of the severe COVID-19 disease course. In view of the recent report of a child with an autoinflammatory disease and a homozygous nonsense variant in <i>TBK1</i><sup><a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Kosukcu, C. et al. Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline? Rheumatol. 60, 607–616 (2021)." href=#ref-CR14 id=ref-link-section-d7690178e1347>14</a></sup>, the present <i>TBK1</i> variant might also have been the causal factor for the child’s preexisting, unclassified autoinflammatory disease.<p>In general, our data suggest that genetic testing of children with severe COVID-19 is warranted in order to identify monogenic factors, such as defects in type I IFN defense, which may drive a severe disease course. This could identify groups of individuals who are particularly susceptible to severe COVID-19, and who might benefit form special protective measures or specific therapeutic approaches.</p></div></div></section><section data-title=Methods><div class=c-article-section id=Sec8-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec8>Methods</h2><div class=c-article-section__content id=Sec8-content><h3 class=c-article__sub-heading id=Sec9>Human participants</h3><p>Prior to the molecular analyses, written informed consent was obtained from both parents, including consent to the potential scientific use of the results. After the analyses were completed, the results were discussed with the parents and the parents agreed to a publication as a case report. Our case report is a retrospective report of a clinical case and its diagnostic work-up. Thus, the report is not part of a planned scientific study. The relevant ethics committee of the University of Bonn was informed about the planned publication of the case report and has approved the procedure.<h3 class=c-article__sub-heading id=Sec10>Trio exome sequencing</h3><p>Exome sequencing was conducted at the Institute of Human Genetics of the University of Bonn as part of the routine diagnostic work-up. DNA was extracted from peripheral blood leukocytes. All coding genomic target regions (exome), as well as the adjacent intronic regions, were enriched using the SureSelect Human All Exon V6 Enrichment Kit (Agilent Technologies, Santa Clara, California). These were sequenced on a NextSeq system (Illumina, San Diego, California) as 2 × 100 bp paired-end reads. Alignment to the reference genome GRCh37/hg19 was performed using the Burrow Wheeler Aligner software (BWA version 0.7.17-r1188). Subsequent variant calling was performed in accordance with the “GATK Best Practice” guidelines (GATK version 4.1.3.0). In total, 90% of the target regions were covered at least 20-fold, and 94% were covered at least tenfold.<p>The filtering and prioritization strategy is outlined in Table <a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a>. Annotation and filtering were performed using Ensembl Variant Effect Predictor (VEP, version 97, <a href=http://www.ensembl.org/info/docs/tools/vep/>www.ensembl.org/info/docs/tools/vep/</a>). First, filtering was performed for variants with an allele frequency of &lt;2% in subcohorts of the population-based databases Genome Aggregation Database (gnomAD, v2.1.1); Exome Variant Server (EVS); and 1000Genomes; and with &lt;5 reported homozygous occurrences in gnomAD. Next, filtering was performed for variants with a high or moderate impact—as predicted by VEP—or with a spliceAI-score of &gt;0.1 in any category (<a href=https://github.com/Illumina/SpliceAI>https://github.com/Illumina/SpliceAI</a>). This corresponds to non-synonymous single nucleotide variants; insertions and deletions (indels); and variants with potential effects on splice sites. To prioritize variants in genes of relevance to the present phenotype, a gene list was compiled, which was mainly based on terms from the Human Phenotype Ontology (HPO), and gene panels from the Genomics England PanelApp (<a href=https://panelapp.genomicsengland.co.uk/>https://panelapp.genomicsengland.co.uk/</a>). The list of genes is provided in Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>. To prioritize variants with a recessive or dominant inheritance pattern, a filter for high quality variants (QD &gt;2.0 and FS &lt;60.0 and MQ &gt;40.0 and MQRankSum &gt; −12.5 and ReadPosRankSum &gt; −8.0) was first applied. Homozygous, compound heterozygous, and potential de novo variants were then identified using the tool VASE (version 0.24, <a href=https://github.com/david-a-parry/vase>https://github.com/david-a-parry/vase</a>). Potential de novo variants underwent additional filtering to ensure a genotype quality (GQ) of &gt;50 in each individual. Variants were assessed by at least two independent exome evaluators, who evaluated the variants on the basis of estimated pathogenicity following the ACMG/AMP guidelines; segregation; potential relevance to the phenotype; and the appearance of raw sequencing data (see also Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>). As a complementary analysis, human leukocyte antigen (HLA) typing was performed using exome data (see Supplementary Note and Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>). The <i>TBK1</i> variant was confirmed at the genomic DNA-level using standard Sanger sequencing (F-primer: TGGGCCATAAGTAACCAATGAG and R-primer: GGGAGCAGATGTGTGAACCT).<h3 class=c-article__sub-heading id=Sec11>Transcript analysis</h3><p>Blood samples were collected from the parents using the PaxGene Blood RNA Kit (PreAnalytiX, Switzerland), and RNA was extracted in accordance with the manufacturer’s protocol. RNA was quantified using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, Massachusetts), and reverse transcribed into cDNA using SuperScript II and oligodT primers. A cDNA fragment was amplified using the primers AGGCACTCATCCGAAAGACA and CCACCCCTTCCATCTCTTCC, which are located in <i>TBK1</i> exons 14 and 20, respectively. Sanger sequencing was performed using BigDye v 3.1 (Thermo Fisher Scientific). Subsequent capillary electrophoresis was performed on an ABI 3130XL device (Thermo Fisher Scientific). Data analysis was performed using SeqMan (DNAStar Inc, Madison, Wisconsin).<h3 class=c-article__sub-heading id=Sec12>Reporting summary</h3><p>Further information on research design is available in the <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM3>Nature Research Reporting Summary</a> linked to this article.</p></div></div></section>
 
 <section data-title="Data availability"><div class=c-article-section id=data-availability-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=data-availability>Data availability</h2><div class=c-article-section__content id=data-availability-content>
 
 <p>A list of the genes that were prioritized for exome analysis is available in Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>, and the variants with the highest prioritization in our approach are provided in Supplementary Data <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM2>1</a>. The chromatogram files underlying Supplementary Fig. <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM1>1</a> are available upon request. The full exome data set cannot be shared due to a lack of parental consent. Variants were submitted to ClinVar, and are available under accession codes VCV000005302 and VCV001050801.</p>
 </div></div></section><section data-title="Code availability"><div class=c-article-section id=code-availability-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=code-availability>Code availability</h2><div class=c-article-section__content id=code-availability-content>
 
 <p>No previously unreported computer code or algorithm was used. Data analysis was performed using standard tools, as described.</p>
 </div></div></section><div id=MagazineFulltextArticleBodySuffix><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=1.><p class=c-article-references__text id=ref-CR1>CDC COVID-19 Response Team. Coronavirus disease 2019 in Children - United States, February 12-April 2, 2020. <i>Morb. Mortal. Wkly. Rep.</i> <b>69</b>, 422–426 (2020).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=2.><p class=c-article-references__text id=ref-CR2>Bhopal, S. S., Bagaria, J., Olabi, B. &amp; Bhopal, R. Children and young people remain at low risk of COVID-19 mortality. <i>Lancet Child Adolesc. Health</i> <b>5</b>, e12–e13 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXms12itL4%3D aria-label="CAS reference 2">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS2352-4642%2821%2900066-3 aria-label="Article reference 2">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Children%20and%20young%20people%20remain%20at%20low%20risk%20of%20COVID-19%20mortality&amp;journal=Lancet%20Child%20Adolesc.%20Health&amp;volume=5&amp;pages=e12-e13&amp;publication_year=2021&amp;author=Bhopal%2CSS&amp;author=Bagaria%2CJ&amp;author=Olabi%2CB&amp;author=Bhopal%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=3.><p class=c-article-references__text id=ref-CR3>Bixler, D. et al. SARS-CoV-2-associated deaths among persons aged &lt;21 years - United States, February 12-July 31, 2020. <i>Morb. Mortal. Wkly. Rep.</i> <b>69</b>, 1324–1329 (2020).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=4.><p class=c-article-references__text id=ref-CR4>Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. <i>Science</i> <b>370</b>, eabd4570 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXit1eksrrN aria-label="CAS reference 4">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1126%2Fscience.abd4570 aria-label="Article reference 4">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Inborn%20errors%20of%20type%20I%20IFN%20immunity%20in%20patients%20with%20life-threatening%20COVID-19&amp;journal=Science&amp;volume=370&amp;publication_year=2020&amp;author=Zhang%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=5.><p class=c-article-references__text id=ref-CR5>van der Made, C. I. Presence of genetic variants among young men with severe COVID-19. <i>JAMA</i> <b>324</b>, 663–673 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1GmtbjJ aria-label="CAS reference 5">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjama.2020.13719 aria-label="Article reference 5">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Presence%20of%20genetic%20variants%20among%20young%20men%20with%20severe%20COVID-19&amp;journal=JAMA&amp;volume=324&amp;pages=663-673&amp;publication_year=2020&amp;author=van%20der%20Made%2CCI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=6.><p class=c-article-references__text id=ref-CR6>Fallerini, C. et al. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. <i>eLife</i> <b>10</b>, e67569 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.7554%2FeLife.67569 aria-label="Article reference 6">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20Toll-like%20receptor%207%20variants%20with%20life-threatening%20COVID-19%20disease%20in%20males%3A%20findings%20from%20a%20nested%20case-control%20study&amp;journal=eLife&amp;volume=10&amp;publication_year=2021&amp;author=Fallerini%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=7.><p class=c-article-references__text id=ref-CR7>Solanich, X. et al. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series. Preprint at <a href=https://www.medrxiv.org/content/10.1101/2021.03.14.21252289v1>https://www.medrxiv.org/content/10.1101/2021.03.14.21252289v1</a> (2021).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=8.><p class=c-article-references__text id=ref-CR8>Goncalves, A. et al. Functional dissection of the TBK1 molecular network. <i>PloS ONE</i> <b>6</b>, e23971 (2011).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXht1enurrN aria-label="CAS reference 8">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1371%2Fjournal.pone.0023971 aria-label="Article reference 8">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Functional%20dissection%20of%20the%20TBK1%20molecular%20network&amp;journal=PloS%20ONE&amp;volume=6&amp;publication_year=2011&amp;author=Goncalves%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=9.><p class=c-article-references__text id=ref-CR9>Povysil, G. et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. <i>J Clin Invest</i>. (2021) (Epub ahead of print).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=10.><p class=c-article-references__text id=ref-CR10>Kosmicki, J. A. et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. <i>Am J Hum Genet</i>. (2021) (Epub ahead of print).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=11.><p class=c-article-references__text id=ref-CR11>Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S. &amp; Huang, C. Antiviral activities of type I interferons to SARS-CoV-2 infection. <i>Antivir. Res.</i> <b>179</b>, 104811 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXovVCkt7s%3D aria-label="CAS reference 11">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.antiviral.2020.104811 aria-label="Article reference 11">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Antiviral%20activities%20of%20type%20I%20interferons%20to%20SARS-CoV-2%20infection&amp;journal=Antivir.%20Res.&amp;volume=179&amp;publication_year=2020&amp;author=Mantlo%2CE&amp;author=Bukreyeva%2CN&amp;author=Maruyama%2CJ&amp;author=Paessler%2CS&amp;author=Huang%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=12.><p class=c-article-references__text id=ref-CR12>Xia, H. et al. Evasion of type I interferon by SARS-CoV-2. <i>Cell Rep.</i> <b>33</b>, 108234 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFaqtbbE aria-label="CAS reference 12">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.celrep.2020.108234 aria-label="Article reference 12">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Evasion%20of%20type%20I%20interferon%20by%20SARS-CoV-2&amp;journal=Cell%20Rep.&amp;volume=33&amp;publication_year=2020&amp;author=Xia%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=13.><p class=c-article-references__text id=ref-CR13>Hemmi, H. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. <i>J. Exp. Med.</i> <b>199</b>, 1641–1650 (2004).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXltFKlur0%3D aria-label="CAS reference 13">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1084%2Fjem.20040520 aria-label="Article reference 13">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20roles%20of%20two%20IkappaB%20kinase-related%20kinases%20in%20lipopolysaccharide%20and%20double%20stranded%20RNA%20signaling%20and%20viral%20infection&amp;journal=J.%20Exp.%20Med.&amp;volume=199&amp;pages=1641-1650&amp;publication_year=2004&amp;author=Hemmi%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=14.><p class=c-article-references__text id=ref-CR14>Kosukcu, C. et al. Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline? <i>Rheumatol.</i> <b>60</b>, 607–616 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXosF2nurc%3D aria-label="CAS reference 14">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1093%2Frheumatology%2Fkeaa165 aria-label="Article reference 14">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Whole%20exome%20sequencing%20in%20unclassified%20autoinflammatory%20diseases%3A%20more%20monogenic%20diseases%20in%20the%20pipeline%3F&amp;journal=Rheumatol.&amp;volume=60&amp;pages=607-616&amp;publication_year=2021&amp;author=Kosukcu%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=15.><p class=c-article-references__text id=ref-CR15>Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. <i>Nat. Genet.</i> <b>37</b>, 820–828 (2005).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2MXmsFKlsr4%3D aria-label="CAS reference 15">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fng1600 aria-label="Article reference 15">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Mutations%20in%20TNFRSF13B%20encoding%20TACI%20are%20associated%20with%20common%20variable%20immunodeficiency%20in%20humans&amp;journal=Nat.%20Genet.&amp;volume=37&amp;pages=820-828&amp;publication_year=2005&amp;author=Salzer%2CU">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=16.><p class=c-article-references__text id=ref-CR16>Fried, A. J., Rauter, I., Dillon, S. R., Jabara, H. H. &amp; Geha, R. S. Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency. <i>J. Allergy Clin. Immunol.</i> <b>128</b>, 226–228 (2011).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXosFaku78%3D aria-label="CAS reference 16">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaci.2011.01.048 aria-label="Article reference 16">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Functional%20analysis%20of%20transmembrane%20activator%20and%20calcium-modulating%20cyclophilin%20ligand%20interactor%20%28TACI%29%20mutations%20associated%20with%20common%20variable%20immunodeficiency&amp;journal=J.%20Allergy%20Clin.%20Immunol.&amp;volume=128&amp;pages=226-228&amp;publication_year=2011&amp;author=Fried%2CAJ&amp;author=Rauter%2CI&amp;author=Dillon%2CSR&amp;author=Jabara%2CHH&amp;author=Geha%2CRS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=17.><p class=c-article-references__text id=ref-CR17>Martinez-Gallo, M. et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. <i>J. Allergy Clin. Immunol.</i> <b>131</b>, 468–476 (2013).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvVais7rI aria-label="CAS reference 17">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaci.2012.10.029 aria-label="Article reference 17">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=TACI%20mutations%20and%20impaired%20B-cell%20function%20in%20subjects%20with%20CVID%20and%20healthy%20heterozygotes&amp;journal=J.%20Allergy%20Clin.%20Immunol.&amp;volume=131&amp;pages=468-476&amp;publication_year=2013&amp;author=Martinez-Gallo%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=18.><p class=c-article-references__text id=ref-CR18>Lee, J. J. et al. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. <i>J. Allergy Clin. Immunol.</i> <b>126</b>, 1234–1241 (2010).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsFantbfO aria-label="CAS reference 18">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaci.2010.08.017 aria-label="Article reference 18">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20C104R%20mutant%20impairs%20the%20function%20of%20transmembrane%20activator%20and%20calcium%20modulator%20and%20cyclophilin%20ligand%20interactor%20%28TACI%29%20through%20haploinsufficiency&amp;journal=J.%20Allergy%20Clin.%20Immunol.&amp;volume=126&amp;pages=1234-1241&amp;publication_year=2010&amp;author=Lee%2CJJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=19.><p class=c-article-references__text id=ref-CR19>Bacchelli, C. et al. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. <i>J. Allergy Clin. Immunol.</i> <b>127</b>, 1253–1259 (2011).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXlsFWmsb4%3D aria-label="CAS reference 19">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaci.2011.02.037 aria-label="Article reference 19">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20C76R%20transmembrane%20activator%20and%20calcium%20modulator%20cyclophilin%20ligand%20interactor%20mutation%20disrupts%20antibody%20production%20and%20B-cell%20homeostasis%20in%20heterozygous%20and%20homozygous%20mice&amp;journal=J.%20Allergy%20Clin.%20Immunol.&amp;volume=127&amp;pages=1253-1259&amp;publication_year=2011&amp;author=Bacchelli%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=20.><p class=c-article-references__text id=ref-CR20>Agarwal, S. &amp; Cunningham-Rundles, C. Autoimmunity in common variable immunodeficiency. <i>Ann. Allergy Asthma Immunol.</i> <b>123</b>, 454–460 (2019).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhsFCmtbrF aria-label="CAS reference 20">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.anai.2019.07.014 aria-label="Article reference 20">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Autoimmunity%20in%20common%20variable%20immunodeficiency&amp;journal=Ann.%20Allergy%20Asthma%20Immunol.&amp;volume=123&amp;pages=454-460&amp;publication_year=2019&amp;author=Agarwal%2CS&amp;author=Cunningham-Rundles%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=21.><p class=c-article-references__text id=ref-CR21>Martínez-Pomar, N. et al. Role of TNFRSF13B variants in patients with common variable immunodeficiency. <i>Blood</i> <b>114</b>, 2846–2848 (2009).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1182%2Fblood-2009-05-213025 aria-label="Article reference 21">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Role%20of%20TNFRSF13B%20variants%20in%20patients%20with%20common%20variable%20immunodeficiency&amp;journal=Blood&amp;volume=114&amp;pages=2846-2848&amp;publication_year=2009&amp;author=Mart%C3%ADnez-Pomar%2CN">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=22.><p class=c-article-references__text id=ref-CR22>Koopmans, W. et al. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). <i>J. Clin. Immunol.</i> <b>33</b>, 68–73 (2013).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXhslamtLg%3D aria-label="CAS reference 22">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1007%2Fs10875-012-9793-x aria-label="Article reference 22">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20variability%20of%20family%20members%20with%20the%20C104R%20mutation%20in%20transmembrane%20activator%20and%20calcium%20modulator%20and%20cyclophilin%20ligand%20interactor%20%28TACI%29&amp;journal=J.%20Clin.%20Immunol.&amp;volume=33&amp;pages=68-73&amp;publication_year=2013&amp;author=Koopmans%2CW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=23.><p class=c-article-references__text id=ref-CR23>Quinti, I. et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. <i>J. Allergy Clin. Immunol.</i> <b>146</b>, 211–213 (2020). e4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXoslekt7o%3D aria-label="CAS reference 23">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaci.2020.04.013 aria-label="Article reference 23">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20possible%20role%20for%20B%20cells%20in%20COVID-19%3F%20Lesson%20from%20patients%20with%20agammaglobulinemia&amp;journal=J.%20Allergy%20Clin.%20Immunol.&amp;volume=146&amp;pages=211-213&amp;publication_year=2020&amp;author=Quinti%2CI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=24.><p class=c-article-references__text id=ref-CR24>Fill, L., Hadney, L., Graven, K., Persaud, R. &amp; Hostoffer, R. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019. <i>Ann. Allergy Asthma Immunol.</i> <b>125</b>, 112–114 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXptVeqtL4%3D aria-label="CAS reference 24">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.anai.2020.04.033 aria-label="Article reference 24">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20clinical%20observation%20of%20a%20patient%20with%20common%20variable%20immunodeficiency%20diagnosed%20as%20having%20coronavirus%20disease%202019&amp;journal=Ann.%20Allergy%20Asthma%20Immunol.&amp;volume=125&amp;pages=112-114&amp;publication_year=2020&amp;author=Fill%2CL&amp;author=Hadney%2CL&amp;author=Graven%2CK&amp;author=Persaud%2CR&amp;author=Hostoffer%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=25.><p class=c-article-references__text id=ref-CR25>Mullur, J., Wang, A. &amp; Feldweg, A. A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency. <i>Ann. Allergy Asthma Immunol.</i> <b>126</b>, 90–92 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslSltrjP aria-label="CAS reference 25">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.anai.2020.08.017 aria-label="Article reference 25">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20fatal%20case%20of%20coronavirus%20disease%202019%20in%20a%20patient%20with%20common%20variable%20immunodeficiency&amp;journal=Ann.%20Allergy%20Asthma%20Immunol.&amp;volume=126&amp;pages=90-92&amp;publication_year=2021&amp;author=Mullur%2CJ&amp;author=Wang%2CA&amp;author=Feldweg%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=26.><p class=c-article-references__text id=ref-CR26>Cohen, B. et al. COVID-19 infection in 10 common variable immunodeficiency patients in New York City. <i>J. Allergy Clin. Immunol. Pract.</i> <b>9</b>, 504–507 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jaip.2020.11.006 aria-label="Article reference 26">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20infection%20in%2010%20common%20variable%20immunodeficiency%20patients%20in%20New%20York%20City&amp;journal=J.%20Allergy%20Clin.%20Immunol.%20Pract.&amp;volume=9&amp;pages=504-507&amp;publication_year=2021&amp;author=Cohen%2CB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=27.><p class=c-article-references__text id=ref-CR27>van Damme, K. F. A. et al. Case report: convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19. <i>Front. Immunol.</i> <b>11</b>, 596761 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.3389%2Ffimmu.2020.596761 aria-label="Article reference 27">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Case%20report%3A%20convalescent%20plasma%2C%20a%20targeted%20therapy%20for%20patients%20with%20CVID%20and%20severe%20COVID-19&amp;journal=Front.%20Immunol.&amp;volume=11&amp;publication_year=2020&amp;author=Damme%2CKFA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=28.><p class=c-article-references__text id=ref-CR28>Strangfeld, A. et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. <i>Ann. Rheum. Dis.</i> (2021).</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=29.><p class=c-article-references__text id=ref-CR29>Saposnik, G. et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke</i> <b>42</b>, 1158–1192 (2011).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1161%2FSTR.0b013e31820a8364 aria-label="Article reference 29">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Diagnosis%20and%20management%20of%20cerebral%20venous%20thrombosis%3A%20a%20statement%20for%20healthcare%20professionals%20from%20the%20American%20Heart%20Association%2FAmerican%20Stroke%20Association&amp;journal=Stroke&amp;volume=42&amp;pages=1158-1192&amp;publication_year=2011&amp;author=Saposnik%2CG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=30.><p class=c-article-references__text id=ref-CR30>Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. &amp; Theocharis, P. Hyperinflammatory shock in children during COVID-19 pandemic. <i>Lancet</i> <b>395</b>, 1607–1608 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXovFKmsLY%3D aria-label="CAS reference 30">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0140-6736%2820%2931094-1 aria-label="Article reference 30">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Hyperinflammatory%20shock%20in%20children%20during%20COVID-19%20pandemic&amp;journal=Lancet&amp;volume=395&amp;pages=1607-1608&amp;publication_year=2020&amp;author=Riphagen%2CS&amp;author=Gomez%2CX&amp;author=Gonzalez-Martinez%2CC&amp;author=Wilkinson%2CN&amp;author=Theocharis%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=31.><p class=c-article-references__text id=ref-CR31>Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. <i>JAMA</i> <b>325</b>, 1074–1087 (2021).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXntVWis70%3D aria-label="CAS reference 31">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjama.2021.2091 aria-label="Article reference 31">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Characteristics%20and%20outcomes%20of%20US%20children%20and%20adolescents%20with%20multisystem%20inflammatory%20syndrome%20in%20children%20%28MIS-C%29%20compared%20with%20severe%20acute%20COVID-19&amp;journal=JAMA&amp;volume=325&amp;pages=1074-1087&amp;publication_year=2021&amp;author=Feldstein%2CLR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=32.><p class=c-article-references__text id=ref-CR32>Barnkob, M. B. et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. <i>Blood Adv.</i> <b>4</b>, 4990–4993 (2020).<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXis12ksbzI aria-label="CAS reference 32">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1182%2Fbloodadvances.2020002657 aria-label="Article reference 32">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Reduced%20prevalence%20of%20SARS-CoV-2%20infection%20in%20ABO%20blood%20group%20O&amp;journal=Blood%20Adv.&amp;volume=4&amp;pages=4990-4993&amp;publication_year=2020&amp;author=Barnkob%2CMB">
 Google Scholar</a>&nbsp;
 </p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link href="https://citation-needed.springer.com/v2/references/10.1038/s41525-021-00220-w?format=refman&amp;flavour=references">Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a></p></div></div></div></section></div><section data-title=Acknowledgements><div class=c-article-section id=Ack1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Ack1>Acknowledgements</h2><div class=c-article-section__content id=Ack1-content><p>We thank the next generation sequencing (NGS) core facility of the University Hospital of Bonn for the generation of the sequencing data.</p></div></div></section><section data-title=Funding><div class=c-article-section id=Fun-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Fun>Funding</h2><div class=c-article-section__content id=Fun-content><p>Open Access funding enabled and organized by Projekt DEAL.</p></div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><span class="c-article-author-information__subtitle u-visually-hidden" id=author-notes>Author notes</span><ol class=c-article-author-information__list><li class=c-article-author-information__item id=na1><p>These authors contributed equally: Axel Schmidt, Sophia Peters, Alexej Knaus.</p></ol><h3 class=c-article__sub-heading id=affiliations>Authors and Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Axel Schmidt,&nbsp;Sophia Peters,&nbsp;Julia Fazaal,&nbsp;Kerstin U. Ludwig,&nbsp;Hartmut Engels&nbsp;&amp;&nbsp;Markus M. Nöthen</p><li id=Aff2><p class=c-article-author-affiliation__address>Institute of Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Alexej Knaus,&nbsp;Carlo Maj,&nbsp;Sugirthan Sivalingam,&nbsp;Aakash Mantri&nbsp;&amp;&nbsp;Peter M. Krawitz</p><li id=Aff3><p class=c-article-author-affiliation__address>Neonatology and Pediatric Intensive Care, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Hemmen Sabir,&nbsp;Andreas Müller&nbsp;&amp;&nbsp;Soyhan Bagci</p><li id=Aff4><p class=c-article-author-affiliation__address>Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany<p class=c-article-author-affiliation__authors-list>Frauke Hamsen,&nbsp;Dirk Holzinger&nbsp;&amp;&nbsp;Ulrich Neudorf</p><li id=Aff5><p class=c-article-author-affiliation__address>Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Sugirthan Sivalingam</p><li id=Aff6><p class=c-article-author-affiliation__address>Core Unit for Bioinformatics Data Analysis, Medical Faculty, University of Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Sugirthan Sivalingam</p><li id=Aff7><p class=c-article-author-affiliation__address>Department of Diagnostic and Interventional Radiology, University of Bonn, School of Medicine &amp; University Hospital Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Oleksandr Savchenko</p></ol><div class="u-js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=contributions>Contributions</h3><p>A.S., S.P., A.K., H.E., K.U.L., P.M.K., and M.M.N. contributed to the generation, analysis, and interpretation of the genetic data. J.F. conducted the validation experiments. C.M., S.S., and A.Ma. performed the computational analyses. H.S., F.H., O.S., D.H., U.N., A.Mü., and S.B. were responsible for the clinical management of the patient and provided data concerning the clinical evaluation of disease course. A.S., M.M.N., and S.B. conceived and drafted the manuscript. All coauthors revised the draft manuscript texts, and have approved the submission of the final version for publication. A.S., S.P., and A.K. contributed equally to the study.<h3 class=c-article__sub-heading id=corresponding-author>Corresponding author</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 href=mailto:markus.noethen@uni-bonn.de>Markus M. Nöthen</a>.</p></div></div></section><section data-title="Ethics declarations"><div class=c-article-section id=ethics-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=ethics>Ethics declarations</h2><div class=c-article-section__content id=ethics-content>
 
 <h3 class=c-article__sub-heading id=FPar1>Competing interests</h3>
 <p>The authors declare no competing interests.</p>
 
 </div></div></section><section data-title="Additional information"><div class=c-article-section id=additional-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=additional-information>Additional information</h2><div class=c-article-section__content id=additional-information-content><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Supplementary information"><div class=c-article-section id=Sec13-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec13>Supplementary information</h2><div class=c-article-section__content id=Sec13-content><div data-test=supplementary-info><div id=figshareContainer class=c-article-figshare-container data-test=figshare-container></div>
 
 
 
 <div class=c-article-supplementary__item data-test=supp-item id=MOESM1><h3 class="c-article-supplementary__title u-h3"><a class=print-link data-track=click data-track-action="view supplementary info" data-track-label=link data-test=supp-info-link href=https://static-content.springer.com/esm/art%3A10.1038%2Fs41525-021-00220-w/MediaObjects/41525_2021_220_MOESM1_ESM.pdf data-supp-info-image>Supplementary Information</a></h3></div><div class=c-article-supplementary__item data-test=supp-item id=MOESM2><h3 class="c-article-supplementary__title u-h3"><a class=print-link data-track=click data-track-action="view supplementary info" data-track-label=link data-test=supp-info-link href=https://static-content.springer.com/esm/art%3A10.1038%2Fs41525-021-00220-w/MediaObjects/41525_2021_220_MOESM2_ESM.xlsx data-supp-info-image>Supplementary Data 1</a></h3></div><div class=c-article-supplementary__item data-test=supp-item id=MOESM3><h3 class="c-article-supplementary__title u-h3"><a class=print-link data-track=click data-track-action="view supplementary info" data-track-label=link data-test=supp-info-link href=https://static-content.springer.com/esm/art%3A10.1038%2Fs41525-021-00220-w/MediaObjects/41525_2021_220_MOESM3_ESM.pdf data-supp-info-image>Reporting Summary</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href=http://creativecommons.org/licenses/by/4.0/ rel=license>http://creativecommons.org/licenses/by/4.0/</a>.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=TBK1%20and%20TNFRSF13B%20mutations%20and%20an%20autoinflammatory%20disease%20in%20a%20child%20with%20lethal%20COVID-19&amp;author=Axel%20Schmidt%20et%20al&amp;contentID=10.1038%2Fs41525-021-00220-w&amp;copyright=The%20Author%28s%29&amp;publication=2056-7944&amp;publicationDate=2021-07-01&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1038/s41525-021-00220-w target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41525-021-00220-w" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg> width=57 height=81></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>Schmidt, A., Peters, S., Knaus, A. <i>et al.</i> <i>TBK1</i> and <i>TNFRSF13B</i> mutations and an autoinflammatory disease in a child with lethal COVID-19.
 <i>npj Genom. Med.</i> <b>6, </b>55 (2021). https://doi.org/10.1038/s41525-021-00220-w<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external href="https://citation-needed.springer.com/v2/references/10.1038/s41525-021-00220-w?format=refman&amp;flavour=citation">Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2021-02-02>02 February 2021</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2021-06-09>09 June 2021</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2021-07-01>01 July 2021</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value>https://doi.org/10.1038/s41525-021-00220-w</span></p></ul><div data-component=share-box><div class="c-article-share-box u-display-inline"><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
 Provided by the Springer Nature SharedIt content-sharing initiative
 </p></div></div><div data-component=article-info-list>
 <h3 class=c-article__sub-heading>Subjects</h3>
 <ul class=c-article-subject-list>
 <li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/autoinflammatory-syndrome data-track=click data-track-action="view subject" data-track-label=link>Autoinflammatory syndrome</a><li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/genetic-testing data-track=click data-track-action="view subject" data-track-label=link>Genetic testing</a><li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/infection data-track=click data-track-action="view subject" data-track-label=link>Infection</a><li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/viral-infection data-track=click data-track-action="view subject" data-track-label=link>Viral infection</a></li>
 </ul>
 </div></div></div></div></div></section>
 
 <section>
 <div class="c-article-section js-article-section" id=further-reading-section>
 <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=further-reading>Further reading</h2>
 <div class="c-article-section__content js-collapsible-section" id=further-reading-content>
 <ul class=c-article-further-reading__list id=further-reading-list>
 
 <li class="c-article-further-reading__item js-ref-item">
 <h3 class=c-article-further-reading__title>
 <a class=print-link data-track=click data-track-action="view further reading article" data-track-label="link:Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome" href=https://doi.org/10.1007/s10875-022-01215-7>
 Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
 </a>
 </h3>
 
 <ul data-test=author-list class="c-author-list c-author-list--compact c-author-list--truncated u-mb-4 u-mt-auto">
 
 <li>Hassan Abolhassani</li>
 
 <li>Nils Landegren</li>
 
 <li>Qiang Pan-Hammarström</li>
 
 </ul>
 
 <p class=c-article-further-reading__journal-title><i>Journal of Clinical Immunology</i> (2022)</p>
 </li>
 
 <li class="c-article-further-reading__item js-ref-item">
 <h3 class=c-article-further-reading__title>
 <a class=print-link data-track=click data-track-action="view further reading article" data-track-label="link:Human genetic and immunological determinants of critical COVID-19 pneumonia" href=https://doi.org/10.1038/s41586-022-04447-0>
 Human genetic and immunological determinants of critical COVID-19 pneumonia
 </a>
 </h3>
 
 <ul data-test=author-list class="c-author-list c-author-list--compact c-author-list--truncated u-mb-4 u-mt-auto">
 
 <li>Qian Zhang</li>
 
 <li>Paul Bastard</li>
 
 <li>Jean-Laurent Casanova</li>
 
 </ul>
 
 <p class=c-article-further-reading__journal-title><i>Nature</i> (2022)</p>
 </li>
 
 <li class="c-article-further-reading__item js-ref-item">
 <h3 class=c-article-further-reading__title>
 <a class=print-link data-track=click data-track-action="view further reading article" data-track-label="link:Multiple drugs" href=https://doi.org/10.1007/s40278-021-99971-z>
 Multiple drugs
 </a>
 </h3>
 
 <p class=c-article-further-reading__journal-title><i>Reactions Weekly</i> (2021)</p>
 </li>
 
 </ul>
 </div>
 </div>
 </section>
 
 
 <span data-recommended=jobs></span>
</div>
</article>
</main>
<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion data-container-type=reading-companion data-track-component="reading companion">
 <div class=js-context-bar-sticky-point-desktop>
 
 
 
 
 
 <div class="c-pdf-download u-clear-both js-pdf-download">
 <a href=https://www.nature.com/articles/s41525-021-00220-w.pdf class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf=true data-readcube-pdf-url=true data-test=download-pdf data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=link data-track-external>
 <span class=c-pdf-download__text>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#global-icon-download></use></svg>
 </a>
 </div>
 
 
 
 </div>
 
 
 
 
 
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:40px>
 <ul class=c-reading-companion__tabs role=tablist><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections role=tabpanel><div class=c-reading-companion__scroll-pane style=max-height:none><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Introduction>Introduction</a><li id=rc-sec-Sec2 class=c-reading-companion__section-item><a href=#Sec2 data-track=click data-track-action="section anchor" data-track-label=link:Results>Results</a><li id=rc-sec-Sec7 class=c-reading-companion__section-item><a href=#Sec7 data-track=click data-track-action="section anchor" data-track-label=link:Discussion>Discussion</a><li id=rc-sec-Sec8 class=c-reading-companion__section-item><a href=#Sec8 data-track=click data-track-action="section anchor" data-track-label=link:Methods>Methods</a><li id=rc-sec-data-availability class=c-reading-companion__section-item><a href=#data-availability data-track=click data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a><li id=rc-sec-code-availability class=c-reading-companion__section-item><a href=#code-availability data-track=click data-track-action="section anchor" data-track-label="link:Code availability">Code availability</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Ack1 class=c-reading-companion__section-item><a href=#Ack1 data-track=click data-track-action="section anchor" data-track-label=link:Acknowledgements>Acknowledgements</a><li id=rc-sec-Fun class=c-reading-companion__section-item><a href=#Fun data-track=click data-track-action="section anchor" data-track-label=link:Funding>Funding</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-ethics class=c-reading-companion__section-item><a href=#ethics data-track=click data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a><li id=rc-sec-additional-information class=c-reading-companion__section-item><a href=#additional-information data-track=click data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a><li id=rc-sec-Sec13 class=c-reading-companion__section-item><a href=#Sec13 data-track=click data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a><li id=rc-sec-further-reading class=c-reading-companion__section-item><a href=#further-reading data-track=click data-track-action="section anchor" data-track-label="link:Further reading">Further reading</a></ul></div>
 <div class=u-mt-16 data-component-mpu>
 <div class="c-ad c-ad--300x250">
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 
 <div id=div-gpt-ad-right-2 class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type=right data-pa11y-ignore data-gpt data-gpt-unitpath=/285/npjgenmed.nature.com/article data-gpt-sizes=300x250 data-gpt-targeting="type=article;pos=right;artid=s41525-021-00220-w;doi=10.1038/s41525-021-00220-w;subjmeta=1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699;kwrd=Autoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection">
 <noscript class=sf-hidden>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/npjgenmed.nature.com/article&amp;sz=300x250&amp;c=-839369593&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41525-021-00220-w%26doi%3D10.1038/s41525-021-00220-w%26subjmeta%3D1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699%26kwrd%3DAutoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/npjgenmed.nature.com/article&amp;sz=300x250&amp;c=-839369593&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41525-021-00220-w%26doi%3D10.1038/s41525-021-00220-w%26subjmeta%3D1512,208,2489,249,2510,2511,2514,254,255,420,631,692,699%26kwrd%3DAutoinflammatory+syndrome,Genetic+testing,Infection,Viral+infection"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
 </div>
 </div>
 </div>
 </div>
 </div>
 
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references role=tabpanel></div>
 </div>
 </div>
</aside>
</div>
 
 
 
 
 
 
 
 
 
 
 
<footer class=composite-layer itemscope itemtype=http://schema.org/Periodical>
 
 
 <div class="u-mt-16 u-mb-16">
 <div class=u-container>
 <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
 
 <p class="c-meta u-ma-0 u-flex-shrink">
 <span class=c-meta__item>
 npj Genomic Medicine (<i>npj Genom. Med.</i>)
 </span>
 
 
 <span class=c-meta__item>
 <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop=onlineIssn>2056-7944</span> (online)
 </span>
 
 
 
 </p>
 </div>
 </div>
</div>
 <div>
 <div class=c-footer>
 <div class=u-container>
 <div class=u-hide-print data-track-component=footer>
 <h2 class=u-visually-hidden>nature.com sitemap</h2>
 <div class=c-footer__header>
 <div class=c-footer__logo>
 <img alt="Nature portfolio" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMjAwIiBoZWlnaHQ9IjMxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjxnIGZpbGw9IiNGRkYiIGZpbGwtcnVsZT0ibm9uemVybyI+PHBhdGggZD0iTTk4LjgzNyA3LjM2MmMtMi44NjggMC00LjU3MyAxLjc4My01LjE5NCAzLjU2NmgtLjA3N3YtMy40MWgtLjA3OEw4OS41MzUgOC42OGMuNTQzLjY5Ny45MyAyLjMyNS45MyA0LjE4NXYxMi42MzJjMCAxLjc4My0uMDc3IDMuOTUzLS40NjUgNS41MDNoNC4xMDljLS4zODgtMS41NS0uNDY2LTMuNDEtLjQ2Ni01LjUwM3YtMS4xNjJjMS4xNjMuMzg3IDIuMDkzLjU0MyAzLjQxMS41NDMgNS44OTIgMCA4LjIxNy00LjcyOCA4LjIxNy05LjMgMC01LjQyNS0yLjcxMy04LjIxNS02LjQzNC04LjIxNXpNOTcuMDU0IDIzLjI1Yy0xLjcwNSAwLTIuNzEzLS42OTgtMy40MS0xLjM5NVYxMS41NDdjLjc3NS0xLjE2MiAyLjAxNS0xLjg2IDMuNzItMS44NiAzLjE3OSAwIDQuNTc0IDIuMDkzIDQuNTc0IDYuMjc4IDAgNC42NS0xLjM5NSA3LjI4NS00Ljg4NCA3LjI4NXptMTcuNTItMTUuODFjLTQuMDMxIDAtNy43NTIgMy40MS03Ljc1MiA4LjgzNSAwIDUuMTE1IDMuNTY2IDguNjAzIDguMDYyIDguNjAzIDQuMDMgMCA3Ljc1Mi0zLjQxIDcuNzUyLTguODM1IDAtNS4xMTUtMy40ODktOC42MDMtOC4wNjItOC42MDN6bS4zMSAxNS44ODdjLTIuNzEzIDAtNC41NzQtMi4wOTItNC41NzQtNy4zNjIgMC01LjAzNyAxLjYyOC02Ljk3NSA0LjI2NC02Ljk3NSAyLjcxMyAwIDQuNTczIDIuMDkyIDQuNTczIDcuMzYyIDAgNS4wMzgtMS42MjggNi45NzYtNC4yNjMgNi45NzZ6bTE2Ljg5OS0xNS45NjVjLTIuMjQ4IDAtMy42NDMgMS4zOTYtNC4yNjQgNC4xMDhoLS4wNzdWNy41MTdsLTMuOTU0IDEuMTYzYy41NDMuNjk3LjkzIDIuMzI1LjkzIDQuMTg1djYuMTIzYzAgMS43ODItLjA3NyAzLjk1Mi0uNDY1IDUuNThoNC4wMzFjLS4zODctMS40NzMtLjM4Ny0zLjQ4OC0uMzg3LTUuNTAzdi01LjI3YzAtMi4wOTIgMS4xNjMtMy44NzUgMi40OC0zLjg3NS40NjYgMCAuNzc2LjMxIDEuMDg2LjY5Ny4zMS4zMS42Mi42MiAxLjMxOC42MiAxLjA4NSAwIDEuNjI4LS42MiAxLjYyOC0xLjc4Mi0uMDc4LTEuMzk1LTEuMDg2LTIuMDkzLTIuMzI2LTIuMDkzem0xOC4zNzIgMi40MDNoMy41NjZsLjM4OC0xLjkzOGgtMy45NTR2LTIuNzljMC0yLjU1NyAxLjA4NS0zLjQ4NyAyLjQ4LTMuNDg3LjY5OCAwIDEuMDA4LjMxIDEuMjQxIDEuMTYyLjMxIDEuMDA4Ljc3NSAxLjQ3MyAxLjYyOCAxLjQ3My44NTMgMCAxLjQ3My0uNjIgMS40NzMtMS41NSAwLTEuNDcyLTEuNDczLTIuNDgtMy44NzYtMi40OC0zLjQ4OSAwLTYuMDQ3IDIuMjQ4LTYuMDQ3IDYuNTFWNy43NUgxNDBWNC40MThoLS4wNzhsLTUuMDM4IDUuMjd2LjA3N2gxLjkzOHYxMC40NjJjMCAzLjE3OCAxLjM5NSA0LjY1IDQuNDE4IDQuNjUgMS43ODMgMCAyLjk0Ni0uNzc0IDMuNDExLTEuODYuMTU1LS4zODcuMTU1LS42Mi4yMzMtMS4wMDctLjYyLjMxLTEuMzk2LjQ2NS0yLjQ4LjQ2NS0xLjQ3NCAwLTIuNDgyLS42OTgtMi40ODItMi40OFY5Ljc2NWg3LjA1NXY5LjIyM2MwIDEuNzgyLS4wNzggMy45NTItLjQ2NSA1LjU4aDQuMjYzYy0uNDY1LTEuNTUtLjYyLTMuNzItLjYyLTUuNThWOS43NjR6Ii8+PHBhdGggZD0iTTE2MS4zMTggNy40NGMtNC4wMzEgMC03Ljc1MiAzLjQxLTcuNzUyIDguODM1IDAgNS4xMTUgMy41NjYgOC42MDMgOC4wNjIgOC42MDMgNC4wMyAwIDcuNzUyLTMuNDEgNy43NTItOC44MzUgMC01LjExNS0zLjQ4OS04LjYwMy04LjA2Mi04LjYwM3ptLjMxIDE1Ljg4N2MtMi43MTMgMC00LjU3NC0yLjA5Mi00LjU3NC03LjM2MiAwLTUuMDM3IDEuNjI4LTYuOTc1IDQuMjY0LTYuOTc1IDIuNzEzIDAgNC41NzMgMi4wOTIgNC41NzMgNy4zNjIuMDc4IDUuMDM4LTEuNjI3IDYuOTc2LTQuMjYzIDYuOTc2em0xMi45NDYtMTkuMDY1YzAtLjMxLjA3Ny0zLjcyLjA3Ny00LjI2MmgtLjA3N2wtNC4wMzEgMS4xNjNjLjU0Mi42OTcuOTMgMi4zMjQuOTMgNC4xODVWMTguOTFjMCAxLjc4Mi0uMDc4IDMuOTUzLS40NjUgNS41OGg0LjEwOGMtLjQ2NS0xLjYyNy0uNDY1LTMuNzk3LS40NjUtNS41OFY0LjI2MmgtLjA3N3ptNy4wNTQgNy4yODVsLjA3Ny00LjAzLTQuMTA4IDEuMTYzYy41NDMuNjk3LjkzIDIuMzI1LjkzIDQuMTg1djYuMTIzYzAgMS43ODItLjA3NyAzLjk1Mi0uNDY1IDUuNThoNC4xMDljLS40NjYtMS42MjgtLjQ2Ni0zLjc5OC0uNDY2LTUuNTh2LTcuNDRoLS4wNzd6bS0xLjc4My02LjM1NWMxLjI0IDAgMi4wOTMtLjkzIDIuMDkzLTIuMDE0IDAtMS4xNjMtLjg1My0yLjAxNS0yLjA5My0yLjAxNS0xLjE2MyAwLTIuMDE2LjkzLTIuMDE2IDIuMDE0IDAgMS4wODYuODUzIDIuMDE1IDIuMDE2IDIuMDE1em0xMS44NiAyLjI0OGMtNC4wMyAwLTcuNzUyIDMuNDEtNy43NTIgOC44MzUgMCA1LjExNSAzLjU2NiA4LjYwMyA4LjA2MyA4LjYwMyA0LjAzIDAgNy43NTEtMy40MSA3Ljc1MS04LjgzNSAwLTUuMTE1LTMuNTY1LTguNjAzLTguMDYyLTguNjAzem0uMzEgMTUuODg3Yy0yLjcxMyAwLTQuNTczLTIuMDkyLTQuNTczLTcuMzYyIDAtNS4wMzcgMS42MjgtNi45NzUgNC4yNjMtNi45NzUgMi43MTQgMCA0LjU3NCAyLjA5MiA0LjU3NCA3LjM2MiAwIDUuMDM4LTEuNjI4IDYuOTc2LTQuMjYzIDYuOTc2ek0xNS41MDUgMTIuNGMwLTMuMzMyLTEuMDA4LTUuMDM4LTQuNDk2LTUuMDM4LTIuMzI2IDAtNC4yNjQgMS4wODUtNS4zNSAzLjcyaC0uMDc3VjcuNTE4bC0uMDc3LS4wNzdMMCA4Ljk5Yy42OTguNzc1IDEuMjQgMi4yNDggMS4yNCAzLjg3NXY2LjA0NWMwIDIuMDE1LS4wNzcgNC4wMy0uNjIgNS41OGg1LjY2Yy0uNDY2LTEuNDczLS41NDQtMy4yNTUtLjU0NC01LjQyNXYtNy40NGMuNzc2LS42OTcgMS42MjgtMS4wMDggMi45NDYtMS4wMDggMS42MjggMCAyLjMyNi42MiAyLjMyNiAyLjE3djYuMjc4YzAgMi4xNy0uMDc4IDMuOTUyLS41NDMgNS40MjVoNS42NTljLS40NjUtMS41NS0uNjItMy41NjUtLjYyLTUuNThWMTIuNHptMTQuNjUxIDcuNTk1di03LjM2M2MwLTMuNTY0LTEuNjI4LTUuMjctNS45NjktNS4yNy0zLjMzMyAwLTYuNTkgMS42MjgtNi41OSAzLjk1MyAwIDEuMTYyLjg1NCAxLjc4MyAxLjg2MSAxLjc4MyAxLjA4NiAwIDEuNzgzLS41NDMgMi4wOTMtMi4yNDguMjMzLTEuMDg1LjYyLTEuNTUgMS43ODMtMS41NSAxLjc4MyAwIDIuNDAzLjkzIDIuNDAzIDIuODY3di4zMWMwIDEuNzA1LTEuMzE3IDIuNDAzLTMuNzIgMy4zMzMtMi41NTkgMS4wMDctNC45NjIgMi4wOTItNC45NjIgNC44MDUgMCAyLjU1OCAxLjcwNiA0LjE4NSA0LjQxOSA0LjE4NSAyLjE3IDAgMy42NDMtLjkzIDQuMzQxLTMuMWguMDc3Yy4wNzggMS42MjggMS4xNjMgMy4xIDMuMzM0IDMuMSAxLjg2IDAgMi43OS0uOTMgMy4yNTYtMi4zMjUuMDc3LS4zMS4xNTUtLjU0My4yMzItMS4wODUtLjIzMi4xNTUtLjY5Ny4yMzItLjkzLjIzMi0xLjA4NS4xNTUtMS42MjgtLjIzMi0xLjYyOC0xLjYyN3ptLTQuNTc0IDEuMzE3Yy0uMzEuNjk4LS43NzUgMS4xNjMtMi4wOTMgMS4xNjMtMS4zMTcgMC0yLjA5My0uOTMtMi4wOTMtMi40MDIgMC0xLjc4My41NDMtMi42MzYgMi4xNy0zLjQxIDEuMjQxLS42MiAxLjcwNi0uODUzIDIuMDE2LTEuMzk2djYuMDQ2em0xMi4yNDgtMS45Mzd2LTkuMDY4aDMuNzk5bC4zMS0yLjU1N2gtNC4xODZWMy43OTdoLS4xNTVsLTYuMzU3IDYuMzU2LS4wNzcuMTU0aDIuMTd2OS43NjZjMCAzLjE3NyAxLjU1IDQuODgyIDQuODA3IDQuODgyIDIuMzI1IDAgMy40MS0uODUyIDQuMDMtMi4xNy4yMzMtLjQ2NS4zMS0uNzc1LjM4OC0xLjM5NS0uNjIuMzEtMS4zMTguNDY1LTIuMzI1LjQ2NS0xLjU1IDAtMi40MDQtLjY5OC0yLjQwNC0yLjQ4em0xOS45MjMtMTEuNzhsLTUuMTk0LjU0MmMuNTQzIDEuNDczLjY5OCAyLjk0NS42OTggNC42NXY3LjgyOGMtLjYyLjg1My0xLjcwNiAxLjMxOC0zLjEwMSAxLjMxOC0xLjcwNSAwLTIuNDAzLTEuMDA4LTIuNDAzLTIuNzEzVjcuNTk1bC01LjExNi41NDJjLjU0MiAxLjQ3My42OTcgMi45NDUuNjk3IDQuNjV2Ni41ODhjMCAzLjMzMiAxLjMxOCA1LjUwMyA1LjA0IDUuNTAzIDIuOTQ1IDAgNC4yNjMtMS41NSA0Ljk2LTMuNzJoLjA3OHYzLjMzMmg1LjAzOWMtLjM4OC0xLjI0LS42OTgtMi40MDItLjY5OC01LjAzN1Y3LjU5NXptMTMuOTUzIDIuMDkzYzAtMS40NzMtLjg1Mi0yLjMyNi0yLjU1OC0yLjMyNi0yLjA5MyAwLTMuNDg4IDEuNDczLTQuMTg2IDQuNDk1aC0uMDc3di00LjM0bC0uMDc4LS4wNzctNS40MjYgMS41NWMuNjk4Ljc3NSAxLjI0IDIuMjQ4IDEuMjQgMy44NzV2Ni4wNDVjMCAyLjAxNS0uMTU1IDQuMDMtLjYyIDUuNThoNS43MzZjLS40NjUtMS40NzMtLjYyLTMuNDg3LS42Mi01LjczNXYtNC4wM2MwLTIuNTU3IDEuMDA4LTQuMTA3IDEuOTM4LTQuMTA3LjY5OCAwIDEuMDg2IDEuMzE3IDIuNjM2IDEuMzE3IDEuMDA4IDAgMi4wMTUtLjkzIDIuMDE1LTIuMjQ4em04LjQ1IDExLjkzNGMtMi44NjggMC00Ljk2MS0xLjg2LTUuMDM5LTUuOTY3di0uMzFoMTBjMC01LjE5My0xLjkzOC03Ljk4My02LjU4OS03Ljk4My00LjU3NCAwLTcuODMgMy43Mi03LjgzIDkuMjIzIDAgNS41MDIgMy41NjcgOC4zNyA3LjkwOCA4LjM3IDMuNzIgMCA1LjgxNC0yLjMyNSA2LjUxMS01LjAzN2wtLjA3Ny0uMjMzYy0uNjk4LjY5OC0yLjE3IDEuOTM4LTQuODg0IDEuOTM4ek03OC40NSA5LjM3N2MyLjAxNSAwIDIuNDggMS43MDUgMi40OCA0LjI2M2wtNS43MzYuNTQyYy4zMS0zLjQxIDEuMzk1LTQuODA1IDMuMjU2LTQuODA1eiIvPjwvZz48L3N2Zz4=" loading=lazy width=200 height=31>
 </div>
 <ul class="c-menu c-menu--inherit u-mr-32">
 <li class=c-menu__item><a class=c-menu__link href=https://www.nature.com/npg_/company_info/index.html data-track=click data-track-action="about us" data-track-label=link>About us</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://www.nature.com/npg_/press_room/press_releases.html data-track=click data-track-action="press releases" data-track-label=link>Press releases</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://press.nature.com/ data-track=click data-track-action="press office" data-track-label=link>Press office</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://support.nature.com/support/home data-track=click data-track-action="contact us" data-track-label=link>Contact us</a></li>
 </ul>
 <ul class="c-menu c-menu--inherit">
 <li class=c-menu__item>
 <a class=c-menu__link href=https://www.facebook.com/NaturePortfolioJournals/ aria-label=Facebook data-track=click data-track-action=facebook data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=16 height=16 viewBox="0 0 20 20"><path d="M2.5 20C1.1 20 0 18.9 0 17.5v-15C0 1.1 1.1 0 2.5 0h15C18.9 0 20 1.1 20 2.5v15c0 1.4-1.1 2.5-2.5 2.5h-3.7v-7.7h2.6l.4-3h-3v-2c0-.9.2-1.5 1.5-1.5h1.6V3.1c-.3 0-1.2-.1-2.3-.1-2.3 0-3.9 1.4-3.9 4v2.2H8.1v3h2.6V20H2.5z"></path></svg>
 </a>
 </li>
 <li class=c-menu__item>
 <a class=c-menu__link href="https://twitter.com/NaturePortfolio?lang=en" aria-label=Twitter data-track=click data-track-action=twitter data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=20 height=20 viewBox="0 0 20 20"><path d="M17.6 4.1c.8-.5 1.5-1.4 1.8-2.4-.8.5-1.7.9-2.6 1-.7-.8-1.8-1.4-3-1.4-2.3 0-4.1 1.9-4.1 4.3 0 .3 0 .7.1 1-3.4 0-6.4-1.8-8.4-4.4C1 2.9.8 3.6.8 4.4c0 1.5.7 2.8 1.8 3.6C2 8 1.4 7.8.8 7.5v.1c0 2.1 1.4 3.8 3.3 4.2-.3.1-.7.2-1.1.2-.3 0-.5 0-.8-.1.5 1.7 2 3 3.8 3-1.3 1.1-3.1 1.8-5 1.8-.3 0-.7 0-1-.1 1.8 1.2 4 1.9 6.3 1.9C13.8 18.6 18 12 18 6.3v-.6c.8-.6 1.5-1.4 2-2.2-.7.3-1.5.5-2.4.6z"></path></svg>
 </a>
 </li>
 <li class=c-menu__item>
 <a class=c-menu__link href=https://www.youtube.com/channel/UCvCLdSgYdSTpWcOgEJgi-ng aria-label=YouTube data-track=click data-track-action=youtube data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=20 height=20 viewBox="0 0 20 20"><path d="M7.9 12.6V6.9l5.4 2.8c0 .1-5.4 2.9-5.4 2.9zM19.8 6s-.2-1.4-.8-2c-.8-.8-1.6-.8-2-.9-2.8-.2-7-.2-7-.2s-4.2 0-7 .2c-.4 0-1.2 0-2 .9-.6.6-.8 2-.8 2S0 7.6 0 9.2v1.5c0 1.7.2 3.3.2 3.3s.2 1.4.8 2c.8.8 1.8.8 2.2.9 1.6.1 6.8.2 6.8.2s4.2 0 7-.2c.4 0 1.2-.1 2-.9.6-.6.8-2 .8-2s.2-1.6.2-3.3V9.2c0-1.6-.2-3.2-.2-3.2z"></path></svg>
 </a>
 </li>
 </ul>
 </div>
 <div class=c-footer__grid>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Discover content</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/siteindex data-track=click data-track-action="journals a-z" data-track-label=link>Journals A-Z</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/subjects/ data-track=click data-track-action="article by subject" data-track-label=link>Articles by subject</a></li>
 <li class=c-footer__item><a href=https://nano.nature.com/ data-track=click data-track-action=nano data-track-label=link>Nano</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/protocolexchange/ data-track=click data-track-action="protocol exchange" data-track-label=link>Protocol Exchange</a></li>
 <li class=c-footer__item><a href=https://www.natureindex.com/ data-track=click data-track-action="nature index" data-track-label=link>Nature Index</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Publishing policies</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/authors/editorial_policies/ data-track=click data-track-action="Nature portfolio policies" data-track-label=link>Nature portfolio policies</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nature-research/open-access data-track=click data-track-action="open access" data-track-label=link>Open access</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Author &amp; Researcher services</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/reprints/ data-track=click data-track-action="reprints and permissions" data-track-label=link>Reprints &amp; permissions</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/authors/research-data data-track=click data-track-action="data research service" data-track-label=link>Research data</a></li>
 <li class=c-footer__item><a href=https://authorservices.springernature.com/go/nr data-track=click data-track-action="language editing" data-track-label=link>Language editing</a></li>
 <li class=c-footer__item><a href=https://authorservices.springernature.com/scientific-editing/ data-track=click data-track-action="scientific editing" data-track-label=link>Scientific editing</a></li>
 <li class=c-footer__item><a href=https://masterclasses.nature.com/ data-track=click data-track-action="nature masterclasses" data-track-label=link>Nature Masterclasses</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/researcher-training/ data-track=click data-track-action="nature research academies" data-track-label=link>Nature Research Academies</a></li>
 <li class=c-footer__item><a href=https://solutions.springernature.com/ data-track=click data-track-action="research solutions" data-track-label=link>Research Solutions</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Libraries &amp; institutions</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/tools-services data-track=click data-track-action="librarian service and tools" data-track-label=link>Librarian service &amp; tools</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/manage-your-account/librarianportal data-track=click data-track-action="librarian portal" data-track-label=link>Librarian portal</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/openresearch/about-open-access/information-for-institutions/ data-track=click data-track-action="open research" data-track-label=link>Open research</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/recommend-to-your-library data-track=click data-track-action="Recommend to library" data-track-label=link>Recommend to library</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Advertising &amp; partnerships</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/digital-advertising/ data-track=click data-track-action=advertising data-track-label=link>Advertising</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/ data-track=click data-track-action="partnerships and services" data-track-label=link>Partnerships &amp; Services</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/media-kits/ data-track=click data-track-action="media kits" data-track-label=link>Media kits</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/branded-content-native-advertising/ data-track-action="branded content" data-track-label=link>Branded content</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Career development</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/naturecareers data-track=click data-track-action="nature careers" data-track-label=link>Nature Careers</a></li>
 <li class=c-footer__item><a href=https://conferences.nature.com/ data-track=click data-track-action="nature conferences" data-track-label=link>Nature<span class=u-visually-hidden> </span> Conferences</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/natureevents/ data-track=click data-track-action="nature events" data-track-label=link>Nature<span class=u-visually-hidden> </span> events</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Regional websites</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/natafrica data-track=click data-track-action="nature africa" data-track-label=link>Nature Africa</a></li>
 <li class=c-footer__item><a href=http://www.naturechina.com/ data-track=click data-track-action="nature china" data-track-label=link>Nature China</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nindia data-track=click data-track-action="nature india" data-track-label=link>Nature India</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/natitaly data-track=click data-track-action="nature Italy" data-track-label=link>Nature Italy</a></li>
 <li class=c-footer__item><a href=https://www.natureasia.com/ja-jp/ data-track=click data-track-action="nature japan" data-track-label=link>Nature Japan</a></li>
 <li class=c-footer__item><a href=https://www.natureasia.com/ko-kr/ data-track=click data-track-action="nature korea" data-track-label=link>Nature Korea</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nmiddleeast/ data-track=click data-track-action="nature middle east" data-track-label=link>Nature Middle East</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Legal &amp; Privacy</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/info/privacy data-track=click data-track-action="privacy policy" data-track-label=link>Privacy Policy</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/cookies data-track=click data-track-action="use of cookies" data-track-label=link>Use of cookies</a></li>
 <li class=c-footer__item><a class=optanon-toggle-display href=https://www.nature.com/articles/s41525-021-00220-w data-cc-action=preferences data-track=click data-track-action="manage cookies" data-track-label=link>Manage cookies/Do not sell my data</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/legal-notice data-track=click data-track-action="legal notice" data-track-label=link>Legal notice</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/accessibility-statement data-track=click data-track-action="accessibility statement" data-track-label=link>Accessibility statement</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/terms-and-conditions data-track=click data-track-action="terms and conditions" data-track-label=link>Terms &amp; Conditions</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/ccpa data-track=click data-track-action="california privacy statement" data-track-label=link>California Privacy Statement</a></li>
 
 <li class=c-footer__item><a href=https://support.nature.com/de/support/solutions/articles/6000255911-k%C3%BCndigungsformular>Cancel contracts here</a></li>
 
 </ul>
 </div>
 </div>
</div>
 </div>
 </div>
 </div>
 <div class=c-corporate-footer>
 <div class=u-container>
 <img src="data:image/svg+xml;base64,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" alt="Springer Nature" loading=lazy width=140 height=14>
 <p class=c-corporate-footer__legal data-test=copyright>© 2022 Springer Nature Limited</p>
 </div>
</div>
 
 <svg class="u-hide hide">
 <symbol id=global-icon-chevron-right viewBox="0 0 16 16">
 <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-download viewBox="0 0 16 16">
 <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-email viewBox="0 0 18 18">
 <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-institution viewBox="0 0 18 18">
 <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-search viewBox="0 0 22 22">
 <path fill-rule=evenodd d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"></path>
 </symbol>
 <symbol id=icon-info viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-success viewBox="0 0 18 18">
 <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-down viewBox="0 0 16 16">
 <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path>
 </symbol>
 <symbol id=icon-warning viewBox="0 0 18 18">
 <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-plus viewBox="0 0 16 16">
 <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-minus viewBox="0 0 16 16">
 <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-error viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-springer-arrow-left>
 <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path>
 </symbol>
 <symbol id=icon-springer-arrow-right>
 <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path>
 </symbol>
 <symbol id=icon-arrow-up viewBox="0 0 16 16">
 <path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-tick viewBox="0 0 24 24">
 <path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z"></path>
 </symbol>
 </svg>
</footer>
 
 
<div class="c-site-messages message u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif" data-component-id=nature-briefing-banner data-component-expirydays=30 data-component-trigger-scroll-percentage=15 data-track=in-view data-track-action=in-view data-track-category="nature briefing" data-track-label="redesign banner visible" data-gtm-vis-first-on-screen-50443292_645=423 data-gtm-vis-total-visible-time-50443292_645=100 data-gtm-vis-has-fired-50443292_645=1>
 
 <div class=c-site-messages__banner-large>
 
<div class=c-site-messages__close-container>
 <button class=c-site-messages__close data-track=click data-track-category="nature briefing" data-track-label="redesign banner dismiss">
 <svg width=25px height=25px focusable=false aria-hidden=true viewBox="0 0 25 25" version=1.1 xmlns=http://www.w3.org/2000/svg xmlns:xlink=http://www.w3.org/1999/xlink>
 <title>Close banner</title>
 <defs></defs>
 <g stroke=none stroke-width=1 fill=none fill-rule=evenodd>
 <rect opacity=0 x=0 y=0 width=25 height=25></rect>
 <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill=#ffffff></path>
 </g>
 </svg>
 <span class=visually-hidden>Close</span>
 </button>
</div>
 <div class=c-site-messages__form-container>
 <div class="grid grid-12 last">
 <div class="grid grid-4">
 <img alt="Nature Briefing" src="data:image/svg+xml;base64,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" width=250 height=40>
 <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing</em> newsletter — what matters in science, free to your inbox daily.</p>
 </div>
 <div class="grid grid-8 last">
 <form action=/briefing/signup/formfeedback method=post data-location=banner data-track=submit data-track-action=transmit-form>
 
 
 <label class=nature-briefing-banner__email-label for=banner-EmailAddressInput>Email address</label>
 <div class=nature-briefing-banner__email-wrapper>
 <input class="nature-briefing-banner__email-input box-sizing text14" type=email id=banner-EmailAddressInput name=email value placeholder="e.g. jo.smith@university.ac.uk" required data-test-element=briefing-emailbanner-email-input>
 <button type=submit class="nature-briefing-banner__submit-button box-sizing text14" data-test-element=briefing-emailbanner-signup-button>Sign up</button>
 </div>
 <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
 <input class=nature-briefing-banner__checkbox-checkbox id=gdpr-briefing-banner-checkbox type=checkbox name=gdpr value=1 data-test-element=briefing-emailbanner-gdpr-checkbox required>
 <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for=gdpr-briefing-banner-checkbox>I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href=https://www.nature.com/info/privacy>Privacy Policy</a>.</label>
 </div>
 </form>
 </div>
 </div>
 </div>
 </div>
 
 <div class="c-site-messages__banner-small sf-hidden">
 
 
 </div>
</div>
 
 
 <noscript class=sf-hidden>
        <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
    </noscript>
 
<img src="data:*/*;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR4nGP6zwAAAgcBApocMXEAAAAASUVORK5CYII=" alt class=u-visually-hidden width=1 height=1>
<noscript class=sf-hidden><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1229240860577415&amp;ev=PageView&amp;noscript=1"></noscript>
<div id=ZN_0CcSRG9GrqrxATc></div>
<div style=width:0px;height:0px;display:none;visibility:hidden id=batBeacon641720954051></div>
<div style=animation-name:expand class="view-pdf-widget expanded"><span class="view-pdf-arrows expanded"></span><a class=view-pdf-text target=_blank href="moz-extension://428f36e2-626f-4ea4-8a69-56f690c7228f/enhanced-reader.html?openApp&amp;pdf=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41525-021-00220-w.pdf">View PDF</a></div>
<div id=criteo-tags-div style=display:none></div><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1><img src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style=display:none width=1 height=1>